{"text_format":"3","workbook":"xls","n_sheets":2,"sheets":["Canonical pathway analysis","Axon guidance signaling"],"not_rendered":{"external_links":1},"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"Canonical pathway analysis","index":0,"n_rows":453,"n_cols":5,"rows_kept":453,"flags":["formulas_cached_only"]}
["© 2000-2019 QIAGEN. All rights reserved."]
["Ingenuity Canonical Pathways"," -log(p-value)","Ratio","z-score","Molecules"]
["G-Protein Coupled Receptor Signaling",10.2,0.139,{"$error":"#NUM!"},"ADRA2B,NAPEPLD,CAMK4,PTK2B,DUSP6,HTR1D,GNA14,RAPGEF4,PDE1A,CHRM1,FGFR3,ADRB1,FGFR4,ADORA1,ADCY8,PRKCA,SMPDL3A,ADCY2,GRM8,GRM1,NPY1R,FGFR1,SSTR3,RGS7,RGS16,FGFR2,GRM4,DRD2,MC4R,GRM5,LPAR1,GAB1,RASGRP1,PDE1B,S1PR1,P2RY12,HTR1F,DUSP4,ADRA2C,ADRA1A,PRKCB"]
["Axonal Guidance Signaling",6.99,0.0986,{"$error":"#NUM!"},"SLIT3,WNT3,ADAMTS20,SEMA6B,ADAMTS2,FGFR3,FGFR4,WNT7B,ABLIM3,BAIAP2,ABLIM2,FZD2,PRKD1,KCNJ12,ADAMTS1,FGFR1,FGFR2,GNAZ,PLCL2,GAB1,ADAM12,NRP1,NTF3,LRRC4C,NTN4,MMP14,SEMA6A,FZD1,GNA14,ROBO1,ABLIM1,IGF1,GLI3,NTNG2,NGFR,ADAMTS17,ERBB2,PRKCA,GNG4,PAK6,NRP2,SLIT2,BMP5,PLXND1,FZD8,SEMA4D,EPHB3,BMP6,WNT11,PRKCB"]
["Factors Promoting Cardiogenesis in Vertebrates",6.96,0.194,{"$error":"#NUM!"},"SMAD9,WNT3,CDC6,FZD1,BMPR1B,BMP5,NOG,FZD8,TGFB2,BMP6,FZD2,CDK2,ACVR2A,WNT11,PRKD1,TCF7L2,PRKCA,PRKCB"]
["Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis",6.46,0.124,{"$error":"#NUM!"},"MAP2K6,CAMK4,SFRP2,PTK2B,WNT3,FRZB,MMP14,FZD1,FGFR3,JUN,IGF1,RUNX2,FGFR4,WNT7B,NGFR,FZD2,IL1RAPL2,SMAD9,FGFR1,FGFR2,BMP5,FZD8,FOS,FOXO1,GAB1,CSF1,SFRP1,BMP6,TCF7L2,WNT11"]
["Molecular Mechanisms of Cancer",6.41,0.102,{"$error":"#NUM!"},"MAP2K6,WNT3,CTNNA1,CDKN2C,BMPR1B,FZD1,GNA14,CCND1,CHEK1,FGFR3,MYC,CDC25B,JUN,WNT7B,FGFR4,TGFB2,RHOBTB2,ADCY8,FZD2,PRKD1,PRKCA,ADCY2,CDC25C,SMAD9,PAK6,FGFR1,FGFR2,GNAZ,AURKA,BMP5,CDK1,FOS,FZD8,GAB1,FOXO1,RND3,RASGRP1,E2F1,BMP6,WNT11,CDK2,PRKCB"]
["Cell Cycle Control of Chromosomal Replication",6.15,0.232,{"$error":"#NUM!"},"LIG1,MCM5,CDC45,MCM6,CDT1,CDC6,POLD1,CDK1,MCM4,MCM3,PCNA,TOP2A,CDK2"]
["Mitotic Roles of Polo-Like Kinase",6.06,0.212,-1.387,"KIF23,CDC25C,CDC20,PLK3,WEE1,PRC1,CCNB2,PLK1,CDK1,CCNB1,CDC25B,PLK2,FBXO5,KIF11"]
["Cell Cycle: G2/M DNA Damage Checkpoint Regulation",5.99,0.245,2.111,"CDC25B,CDC25C,CKS2,WEE1,TOP2A,CCNB2,BORA,PLK1,AURKA,CDK1,CCNB1,CHEK1"]
["cAMP-mediated signaling",5.88,0.121,0,"ADRA2B,NAPEPLD,CAMK4,DUSP6,HTR1D,RAPGEF4,PDE1A,CHRM1,ADRB1,CAMK1G,ADCY8,ADORA1,SMPDL3A,ADCY2,NPY1R,GRM8,RGS7,SSTR3,GRM4,DRD2,MC4R,LPAR1,PDE1B,S1PR1,P2RY12,ADRA2C,DUSP4,HTR1F"]
["Human Embryonic Stem Cell Pluripotency",5.46,0.138,{"$error":"#NUM!"},"NTF3,WNT3,FGFR1,FGFR2,FZD1,BMP5,NOG,FGFR3,FZD8,FOXO1,GAB1,WNT7B,FGFR4,TGFB2,S1PR1,FGFRL1,BMP6,FZD2,WNT11,TCF7L2,SALL4"]
["Neuropathic Pain Signaling In Dorsal Horn Neurons",5.22,0.149,2.828,"GRIN1,GRIN2A,CAMK4,GRM8,GRM1,FGFR1,FGFR2,PLCL2,GRM4,GRM5,FGFR3,FOS,GAB1,FGFR4,CAMK1G,PRKD1,PRKCA,PRKCB"]
["Gαq Signaling",4.77,0.122,1.342,"GNG4,NAPEPLD,CAMK4,PTK2B,GRM1,FGFR1,RGS7,RGS16,FGFR2,GNA14,CHRM1,FGFR3,GRM5,GAB1,RND3,FGFR4,RHOBTB2,ARHGEF25,PRKD1,ADRA1A,PRKCA,PRKCB"]
["IL-7 Signaling Pathway",4.77,0.158,0.302,"FOXO4,FGFR1,FGFR2,FOXG1,BCL6,CCND1,FGFR3,MYC,EBF1,JUN,FOXO1,GAB1,FGFR4,HGF,CDK2"]
["Leukocyte Extravasation Signaling",4.4,0.11,0,"TIMP3,VCAM1,PTK2B,MMP14,FGFR1,JAM2,CTNNA1,THY1,FGFR2,RAPGEF4,SELPLG,FGFR3,GAB1,CLDN1,EZR,RASGRP1,FGFR4,VAV3,DLC1,CLDN3,PRKD1,TIMP2,PRKCA,PRKCB"]
["Gαi Signaling",4.32,0.133,-0.5,"GNG4,ADRA2B,ADCY2,GRM8,NPY1R,SSTR3,RGS7,HTR1D,GRM4,DRD2,LPAR1,S1PR1,P2RY12,HTR1F,ADRA2C,ADCY8,ADORA1"]
["PCP pathway",4.19,0.18,0,"NDP,RSPO3,FZD8,JUN,WNT3,WNT7B,FZD1,JUNB,FZD2,PRICKLE1,WNT11"]
["Protein Kinase A Signaling",4.09,0.0874,-0.174,"NAPEPLD,CAMK4,PTK2B,DUSP6,PTPN5,PDE1A,CDKN3,CDC25B,TH,DUSP5,DUSP3,GLI3,PTPRO,NGFR,TGFB2,ADCY8,PRKD1,PRKCA,SMPDL3A,GNG4,PPP1R14C,CDC25C,PTPRE,PTPRG,ADCY2,PTPRK,PPP1R1B,MAP3K1,PLCL2,CDC14B,PDE1B,DUSP4,PTPRR,TCF7L2,PRKCB,DUSP16"]
["Estrogen-mediated S-phase Entry",4,0.269,-1.134,"MYC,CCNA2,CCNA1,E2F1,CCND1,CDK2,CDK1"]
["Glutamate Receptor Signaling",4,0.172,2,"GRM5,GRIN1,GRIN2A,HOMER2,CAMK4,GRM1,GRM8,SLC1A3,DLG4,SLC1A2,GRM4"]
["Aryl Hydrocarbon Receptor Signaling",3.99,0.121,-1.069,"ALDH1B1,CCND1,CHEK1,MYC,CCNA2,FOS,ALDH1L1,CCNA1,JUN,ALDH1A3,NFIA,E2F1,TGFB2,NFIB,DCT,DHFR,CDK2,AHR"]
["Glioblastoma Multiforme Signaling",3.69,0.108,0.471,"WNT3,FGFR1,FGFR2,PLCL2,FZD1,CCND1,MYC,FGFR3,FZD8,GAB1,RND3,FOXO1,IGF1,WNT7B,FGFR4,E2F1,RHOBTB2,FZD2,CDK2,WNT11"]
["Notch Signaling",3.68,0.211,0.447,"CNTN1,DTX4,MFNG,LFNG,HEY2,DLL3,JAG1,HEY1"]
["CREB Signaling in Neurons",3.64,0.1,2.828,"GNG4,GRIN1,ADCY2,GRIN2A,CAMK4,GRM8,GRM1,FGFR1,FGFR2,GNAZ,PLCL2,GNA14,GRM4,FGFR3,GRM5,GAB1,FGFR4,CACNB2,CACNG8,ADCY8,PRKD1,PRKCA,PRKCB"]
["Regulation of the Epithelial-Mesenchymal Transition Pathway",3.64,0.104,{"$error":"#NUM!"},"MAP2K6,WNT3,FGF9,EGR1,FGFR1,FGFR2,FZD1,FGFR3,FZD8,FGF10,GAB1,WNT7B,FGFR4,HGF,TGFB2,FGFRL1,JAG1,FZD2,CLDN3,WNT11,TCF7L2"]
["Role of NANOG in Mammalian Embryonic Stem Cell Pluripotency",3.59,0.12,0,"WNT3,SMAD9,FGFR1,FGFR2,FZD1,BMPR1B,BMP5,FGFR3,FZD8,GAB1,FGFR4,WNT7B,BMP6,FZD2,WNT11,SALL4"]
["Hepatic Fibrosis / Hepatic Stellate Cell Activation",3.53,0.105,{"$error":"#NUM!"},"COL19A1,VCAM1,CTGF,IL1RAPL2,EDNRB,LHX2,FGFR1,KLF6,FGFR2,COL15A1,Col6a4,IGF1,CSF1,COL23A1,NGFR,HGF,TGFB2,MYH3,IGFBP3,TIMP2"]
["Type II Diabetes Mellitus Signaling",3.53,0.108,1.265,"FGFR1,MAP3K1,FGFR2,KCNJ11,FGFR3,ACSBG1,GAB1,FGFR4,NGFR,ABCC8,ACSL4,CACNB2,MAFA,CACNG8,SMPD3,ACSL1,PRKD1,PRKCA,PRKCB"]
["ErbB Signaling",3.51,0.128,0.277,"MAP2K6,PAK6,FGFR1,FGFR2,FGFR3,FOS,JUN,FOXO1,GAB1,FGFR4,ERBB2,PRKD1,PRKCB,PRKCA"]
["Cardiac Hypertrophy Signaling (Enhanced)",3.47,0.0784,0.632,"ADRA2B,MAP2K6,NAPEPLD,CAMK4,WNT3,FZD1,GNA14,PDE1A,FGFR3,MYC,ADRB1,FGF10,JUN,IGF1,NGFR,WNT7B,FGFR4,TGFB2,ADCY8,FZD2,PRKD1,PRKCA,SMPDL3A,ADCY2,EDNRB,FGFR1,FGF9,MAP3K1,FGFR2,PLCL2,CTF1,FZD8,GAB1,PDE1B,ADRA2C,FGFRL1,ACVR2A,WNT11,ADRA1A,PRKCB"]
["Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis",3.39,0.0871,{"$error":"#NUM!"},"MAP2K6,CAMK4,SFRP2,WNT3,FRZB,FZD1,CCND1,MYC,FGFR3,JUN,WNT7B,FGFR4,NGFR,FZD2,PRKD1,PRKCA,VCAM1,IL1RAPL2,FGFR1,FGFR2,PLCL2,FZD8,FOS,GAB1,CSF1,SFRP1,TCF7L2,WNT11,PRKCB"]
["Synaptogenesis Signaling Pathway",3.35,0.0866,3.402,"GRIN2A,CAMK4,CDH23,LRRTM2,SHC3,CDH11,FGFR3,CNTNAP2,FGFR4,VAMP3,DLG4,CNTNAP1,ADCY8,GRIN1,ADCY2,GRM1,GRM8,FGFR1,FGFR2,GRM4,SNAP25,STXBP6,GRM5,GAB1,SYT6,CDH20,RASGRP1,EPHB3,UNC13A"]
["HGF Signaling",3.32,0.118,0,"FGFR1,MAP3K1,FGFR2,CCND1,FGFR3,FOS,JUN,GAB1,HGF,FGFR4,ELK3,CDK2,PRKD1,PRKCB,PRKCA"]
["Renin-Angiotensin Signaling",3.27,0.113,1.604,"ADCY2,PTK2B,PAK6,FGFR1,MAP3K1,FGFR2,SHC3,FGFR3,FOS,JUN,GAB1,FGFR4,ADCY8,PRKD1,PRKCB,PRKCA"]
["Opioid Signaling Pathway",3.26,0.0923,2.449,"MAP2K6,GRIN1,ADCY2,GRIN2A,RGS20,CAMK4,RGS7,RGS16,KCNJ3,PDE1A,RGS6,MYC,TH,FOS,PDE1B,CAMK1G,CACNB2,RGS8,RGS13,CACNG8,ADCY8,PRKD1,PRKCA,PRKCB"]
["Thrombopoietin Signaling",3.17,0.139,0.905,"FGFR3,MYC,FOS,JUN,GAB1,FGFR1,FGFR4,FGFR2,PRKD1,PRKCA,PRKCB"]
["Wnt/β-catenin Signaling",3.15,0.103,0.243,"SFRP2,FRZB,WNT3,FZD1,CCND1,MYC,FZD8,JUN,SOX21,WNT7B,TLE4,TGFB2,SFRP1,FZD2,ACVR2A,WNT11,TCF7L2,SOX3"]
["ErbB2-ErbB3 Signaling",3.12,0.138,0,"FGFR3,MYC,JUN,GAB1,FOXO1,FGFR1,ETV4,FGFR4,FGFR2,ERBB2,CCND1"]
["UVB-Induced MAPK Signaling",3.12,0.147,0.632,"FGFR3,FOS,JUN,GAB1,FGFR1,FGFR4,FGFR2,PRKD1,PRKCA,PRKCB"]
["Role of CHK Proteins in Cell Cycle Checkpoint Control",3.09,0.158,0.816,"PCNA,CDC25C,RFC4,E2F1,CLSPN,PLK1,CDK2,CDK1,CHEK1"]
["CXCR4 Signaling",3.09,0.0995,0.535,"GNG4,ADCY2,PAK6,EGR1,FGFR1,FGFR2,GNA14,GNAZ,FGFR3,FOS,JUN,GAB1,RND3,FGFR4,RHOBTB2,ADCY8,PRKD1,PRKCA,PRKCB"]
["Cyclins and Cell Cycle Regulation",3.08,0.136,-0.905,"CCNA2,CCNA1,WEE1,E2F1,TGFB2,CDKN2C,CCNB2,CCND1,CDK2,CDK1,CCNB1"]
["Dopamine-DARPP32 Feedback in cAMP Signaling",3.06,0.102,2.309,"KCNJ12,PPP1R14C,GRIN1,ADCY2,GRIN2A,CAMK4,PPP1R1B,KCNJ3,PAWR,PLCL2,DRD2,KCNJ11,KCNJ10,ADCY8,PRKD1,CAMKK2,PRKCA,PRKCB"]
["Adipogenesis pathway",3.04,0.111,{"$error":"#NUM!"},"SMAD9,TXNIP,FGFR1,FGFR2,FZD1,FGFR3,NR1D2,FZD8,EBF1,EGR2,FOXO1,FGFR4,LPL,FGFRL1,FZD2"]
["Chondroitin Sulfate Biosynthesis (Late Stages)",3.03,0.155,-0.333,"CHST2,NDST3,CHSY3,CHST9,HS6ST2,HS3ST1,NDST4,HS3ST4,HS3ST5"]
["FGF Signaling",2.98,0.125,0.577,"FGFR3,MAP2K6,FGF10,GAB1,FGFR1,FGFR4,HGF,FGF9,MAP3K1,FGFR2,FGFRL1,PRKCA"]
["GADD45 Signaling",2.94,0.263,{"$error":"#NUM!"},"PCNA,CCND1,CDK1,CDK2,CCNB1"]
["Prolactin Signaling",2.94,0.124,0.905,"FGFR3,MYC,FOS,JUN,GAB1,FGFR1,FGFR4,FGFR2,NMI,PRKD1,PRKCA,PRKCB"]
["P2Y Purigenic Receptor Signaling Pathway",2.91,0.105,1.807,"GNG4,ADCY2,FGFR1,FGFR2,PLCL2,FGFR3,MYC,FOS,JUN,GAB1,FGFR4,P2RY12,ADCY8,PRKD1,PRKCB,PRKCA"]
["Tec Kinase Signaling",2.9,0.0984,1.604,"GNG4,PAK6,PTK2B,FGFR1,FGFR2,GNA14,GNAZ,STAT4,FGFR3,FOS,RND3,GAB1,FGFR4,VAV3,RHOBTB2,PRKD1,PRKCA,PRKCB"]
["HER-2 Signaling in Breast Cancer",2.86,0.121,{"$error":"#NUM!"},"FGFR3,GAB1,FOXO1,FGFR1,FGFR4,FGFR2,ERBB2,CCND1,ITGB5,PRKD1,PRKCA,PRKCB"]
["p53 Signaling",2.84,0.115,0.333,"FGFR3,PCNA,JUN,GAB1,FGFR1,PLAGL1,PPP1R13B,FGFR4,E2F1,FGFR2,CCND1,CDK2,CHEK1"]
["Cardiac Hypertrophy Signaling",2.83,0.0875,0.894,"MAP2K6,GNG4,ADRA2B,ADCY2,CAMK4,FGFR1,MAP3K1,FGFR2,PLCL2,GNA14,GNAZ,FGFR3,JUN,ADRB1,GAB1,IGF1,RND3,FGFR4,TGFB2,RHOBTB2,ADRA2C,ADCY8,ADRA1A"]
["Basal Cell Carcinoma Signaling",2.83,0.135,0,"FZD8,WNT3,GLI3,WNT7B,FZD1,BMP6,BMP5,FZD2,WNT11,TCF7L2"]
["Relaxin Signaling",2.76,0.0983,1,"SMPDL3A,GNG4,ADCY2,NAPEPLD,FGFR1,FGFR2,GNA14,GNAZ,PDE1A,FGFR3,FOS,JUN,GAB1,FGFR4,PDE1B,CTH,ADCY8"]
["Endothelin-1 Signaling",2.76,0.0913,0,"ADCY2,NAPEPLD,EDNRB,FGFR1,SHC3,FGFR2,PLCL2,GNA14,GNAZ,MYC,FGFR3,FOS,PLA2G4A,JUN,GAB1,FGFR4,ADCY8,PRKD1,PRKCA,PRKCB"]
["Role of NFAT in Cardiac Hypertrophy",2.73,0.089,1.789,"MAP2K6,GNG4,ADCY2,CAMK4,FGFR1,MAP3K1,FGFR2,PLCL2,CTF1,FGFR3,IGF1,GAB1,FGFR4,TGFB2,CAMK1G,CACNB2,CACNG8,ADCY8,PRKD1,PRKCA,PRKCB"]
["Growth Hormone Signaling",2.7,0.122,0.632,"FGFR3,FOS,GAB1,IGF1,FGFR1,FGFR4,IGFBP3,FGFR2,PRKD1,PRKCA,PRKCB"]
["IGF-1 Signaling",2.67,0.11,0.333,"FGFR3,FOS,JUN,CTGF,IGF1,GAB1,FOXO1,FGFR4,FGFR1,IGFBP3,FGFR2,CYR61,GRB10"]
["Glioma Signaling",2.65,0.105,1.508,"CAMK4,FGFR1,FGFR2,CDKN2C,CCND1,FGFR3,GAB1,IGF1,FGFR4,E2F1,CAMK1G,PRKD1,PRKCB,PRKCA"]
["Colorectal Cancer Metastasis Signaling",2.65,0.0846,0.447,"GNG4,ADCY2,WNT3,MMP14,FGFR1,FGFR2,FZD1,CCND1,MYC,FGFR3,FZD8,FOS,JUN,GAB1,RND3,WNT7B,FGFR4,TGFB2,RHOBTB2,ADCY8,FZD2,WNT11,TCF7L2"]
["RANK Signaling in Osteoclasts",2.64,0.114,1.155,"FGFR3,MAP2K6,FOS,JUN,CAMK4,PTK2B,GAB1,MITF,FGFR1,FGFR4,MAP3K1,FGFR2"]
["VEGF Family Ligand-Receptor Interactions",2.64,0.114,0.632,"FGFR3,FOS,PLA2G4A,NRP2,GAB1,FGFR1,FGFR4,FGFR2,PRKD1,PRKCA,NRP1,PRKCB"]
["Macropinocytosis Signaling",2.62,0.12,0,"FGFR3,GAB1,CSF1,FGFR1,FGFR4,HGF,FGFR2,ITGB5,PRKD1,PRKCA,PRKCB"]
["Acute Myeloid Leukemia Signaling",2.61,0.113,0,"FGFR3,MYC,MAP2K6,CCNA1,GAB1,PIM1,FGFR1,FGFR4,FGFR2,JUP,CCND1,TCF7L2"]
["IL-3 Signaling",2.59,0.118,0.302,"FGFR3,FOS,JUN,GAB1,FOXO1,FGFR1,FGFR4,FGFR2,PRKD1,PRKCA,PRKCB"]
["Neurotrophin/TRK Signaling",2.59,0.118,-0.302,"FGFR3,MAP2K6,FOS,NTF3,JUN,GAB1,FGFR1,NGFR,SPRY2,FGFR4,FGFR2"]
["AMPK Signaling",2.58,0.0864,1.291,"ADRA2B,FOXO4,FGFR1,FGFR2,PFKP,FOXG1,CCND1,CHRM1,FGFR3,CCNA2,ADRB1,PCK2,GAB1,FOXO1,SMARCA2,FGFR4,CPT2,AK4,ADRA2C,CAMKK2,ADRA1A"]
["PDGF Signaling",2.57,0.112,1.732,"FGFR3,MYC,SYNJ2,FOS,JUN,GAB1,FGFR1,FGFR4,MAP3K1,FGFR2,PRKCA,PRKCB"]
["LPS/IL-1 Mediated Inhibition of RXR Function",2.53,0.0873,0.816,"ALDH1B1,NDST3,IL1RAPL2,MAP3K1,NDST4,HS3ST4,ABCB9,CHST2,ALDH1L1,ACSBG1,JUN,ALDH1A3,NGFR,CPT2,ACSL4,HS6ST2,FABP7,HS3ST1,ACSL1,HS3ST5"]
["Synaptic Long Term Potentiation",2.53,0.102,1.941,"GRIN1,PPP1R14C,GRIN2A,CAMK4,GRM8,GRM1,GRM4,GNA14,PLCL2,GRM5,ADCY8,PRKD1,PRKCB,PRKCA"]
["Apelin Endothelial Signaling Pathway",2.5,0.101,0,"VCAM1,ADCY2,CAMK4,FGFR1,FGFR2,FGFR3,FOS,JUN,GAB1,FGFR4,ADCY8,PRKD1,PRKCB,PRKCA"]
["T Cell Receptor Signaling",2.45,0.104,{"$error":"#NUM!"},"CD247,CAMK4,FGFR1,MAP3K1,FGFR2,FGFR3,FOS,SHB,JUN,GAB1,FGFR4,VAV3,RASGRP1"]
["GP6 Signaling Pathway",2.44,0.1,1.069,"COL19A1,LAMA5,CAMK4,FGFR1,FGFR2,COL15A1,Col6a4,FGFR3,GAB1,FGFR4,COL23A1,PRKD1,PRKCB,PRKCA"]
["B Cell Receptor Signaling",2.43,0.0891,0.243,"MAP2K6,CAMK4,PTK2B,EGR1,FGFR1,MAP3K1,FGFR2,BCL6,SYNJ2,FGFR3,EBF1,JUN,GAB1,DAPP1,FOXO1,FGFR4,VAV3,PRKCB"]
["Adrenomedullin signaling pathway",2.42,0.0872,1.414,"MAP2K6,TFAP2E,TFAP2C,ADCY2,CALCRL,CAMK4,PTK2B,FGFR1,SHC3,FGFR2,PLCL2,GNA14,FGFR3,FOS,GAB1,FGFR4,RAMP3,CTH,ADCY8"]
["LPS-stimulated MAPK Signaling",2.41,0.112,0.302,"FGFR3,MAP2K6,FOS,JUN,GAB1,FGFR1,FGFR4,FGFR2,PRKD1,PRKCA,PRKCB"]
["Ovarian Cancer Signaling",2.39,0.0955,0.447,"WNT3,FGF9,FGFR1,FGFR2,FZD1,CCND1,FGFR3,FZD8,GAB1,FGFR4,WNT7B,E2F1,FZD2,WNT11,TCF7L2"]
["CCR5 Signaling in Macrophages",2.37,0.111,1.134,"GNG4,CD247,FOS,JUN,CAMK4,PTK2B,CACNB2,CACNG8,PRKD1,PRKCA,PRKCB"]
["Nitric Oxide Signaling in the Cardiovascular System",2.36,0.102,0.832,"CAMK4,FGFR1,FGFR2,PDE1A,CHRM1,FGFR3,ADRB1,GAB1,FGFR4,PDE1B,PRKD1,PRKCA,PRKCB"]
["BMP signaling pathway",2.34,0.116,0.632,"SOSTDC1,JUN,CAMK4,FST,SMAD9,RUNX2,BMPR1B,BMP6,BMP5,NOG"]
["Chondroitin Sulfate Biosynthesis",2.33,0.123,-0.333,"CHST2,NDST3,CHSY3,CHST9,HS6ST2,HS3ST1,NDST4,HS3ST4,HS3ST5"]
["EGF Signaling",2.29,0.122,1,"FGFR3,FOS,JUN,GAB1,FGFR1,FGFR4,MAP3K1,FGFR2,PRKCA"]
["GNRH Signaling",2.23,0.0894,1.387,"MAP2K6,ADCY2,CAMK4,PTK2B,PAK6,EGR1,MAP3K1,GNA14,FOS,JUN,CACNB2,CACNG8,ADCY8,PRKD1,PRKCB,PRKCA"]
["ERK/MAPK Signaling",2.21,0.0849,0.943,"PPP1R14C,PAK6,PTK2B,DUSP6,FGFR1,VRK2,FGFR2,RAPGEF4,MYC,FGFR3,PLA2G4A,FOS,GAB1,FGFR4,DUSP4,ELK3,PRKCA,PRKCB"]
["Endometrial Cancer Signaling",2.18,0.117,0.707,"FGFR3,MYC,GAB1,FGFR1,FGFR4,CTNNA1,FGFR2,ERBB2,CCND1"]
["Glioma Invasiveness Signaling",2.17,0.11,-0.333,"FGFR3,TIMP3,GAB1,RND3,FGFR1,FGFR4,FGFR2,RHOBTB2,ITGB5,TIMP2"]
["Dermatan Sulfate Biosynthesis (Late Stages)",2.17,0.137,-0.378,"CHST2,NDST3,HS6ST2,HS3ST1,NDST4,HS3ST4,HS3ST5"]
["Mismatch Repair in Eukaryotes",2.15,0.222,{"$error":"#NUM!"},"PCNA,RFC4,POLD1,EXO1"]
["Leptin Signaling in Obesity",2.14,0.109,0.378,"FGFR3,NPY,ADCY2,GAB1,FOXO1,FGFR1,FGFR4,FGFR2,PLCL2,ADCY8"]
["nNOS Signaling in Neurons",2.12,0.135,2,"GRIN1,GRIN2A,CAMK4,DLG4,PRKD1,PRKCB,PRKCA"]
["Role of Tissue Factor in Cancer",2.12,0.0949,{"$error":"#NUM!"},"FGFR3,CTGF,GAB1,PTK2B,CSF1,FGFR4,EGR1,FGFR1,FGFR2,GNA14,CYR61,ITGB5,PRKCA"]
["Sphingosine-1-phosphate Signaling",2.09,0.0942,0.577,"FGFR3,ADCY2,GAB1,PTK2B,RND3,FGFR1,FGFR4,S1PR1,FGFR2,RHOBTB2,PLCL2,ADCY8,SMPD3"]
["Ceramide Signaling",2.09,0.102,0,"FGFR3,FOS,JUN,GAB1,FGFR1,NGFR,FGFR4,MAP3K1,S1PR1,FGFR2,SMPD3"]
["Erythropoietin Signaling",2.07,0.106,{"$error":"#NUM!"},"FGFR3,FOS,JUN,GAB1,FGFR1,FGFR4,FGFR2,PRKD1,PRKCA,PRKCB"]
["IL-8 Signaling",2.07,0.0822,0,"GNG4,NAPEPLD,VCAM1,PTK2B,FGFR1,FGFR2,CCND1,FGFR3,FOS,JUN,RND3,GAB1,FGFR4,RHOBTB2,ITGB5,PRKD1,PRKCA,PRKCB"]
["DNA damage-induced 14-3-3σ Signaling",2.07,0.211,{"$error":"#NUM!"},"CCNB2,CDK1,CDK2,CCNB1"]
["eNOS Signaling",2.05,0.0856,1.387,"ADCY2,CAMK4,FGFR1,FGFR2,AQP4,CHRM1,FGFR3,CCNA2,CCNA1,LPAR1,GAB1,FGFR4,ADCY8,PRKD1,PRKCB,PRKCA"]
["GPCR-Mediated Integration of Enteroendocrine Signaling Exemplified by an L Cell",2.03,0.111,-0.333,"ADCY2,GIPR,ADRB1,GRP,GNA14,GALR1,PLCL2,ADCYAP1,ADCY8"]
["Breast Cancer Regulation by Stathmin1",2.03,0.0814,{"$error":"#NUM!"},"GNG4,PPP1R14C,ADCY2,CAMK4,FGFR1,FGFR2,TRPC5,CDK1,FGFR3,GAB1,FGFR4,E2F1,CAMK1G,ADCY8,CDK2,PRKD1,PRKCA,PRKCB"]
["Xenobiotic Metabolism Signaling",2.03,0.0752,{"$error":"#NUM!"},"MAP2K6,ALDH1B1,NDST3,CAMK4,FGFR1,MAP3K1,FGFR2,NDST4,HS3ST4,CHST2,FGFR3,ALDH1L1,GAB1,ALDH1A3,FGFR4,CAMK1G,HS6ST2,HS3ST1,AHR,HS3ST5,PRKD1,PRKCA,PRKCB"]
["Hereditary Breast Cancer Signaling",2.01,0.0892,{"$error":"#NUM!"},"CDC25C,FGFR1,WEE1,FGFR2,CCND1,CDK1,CHEK1,CCNB1,FGFR3,GAB1,RFC4,SMARCA2,FGFR4,E2F1"]
["Melanoma Signaling",2,0.118,-0.378,"FGFR3,GAB1,MITF,FGFR1,FGFR4,E2F1,FGFR2,CCND1"]
["Endocannabinoid Neuronal Synapse Pathway",1.99,0.0915,0.577,"FAAH,GRIN1,GRIN2A,NAPEPLD,ADCY2,GRM1,KCNJ3,GNA14,PLCL2,GRM5,CACNB2,CACNG8,ADCY8"]
["Huntington's Disease Signaling",1.97,0.0775,0.535,"GNG4,GRM1,PACSIN1,FGFR1,FGFR2,GNA14,RCOR2,RPH3A,SNAP25,GRM5,FGFR3,JUN,GAB1,IGF1,FGFR4,VAMP3,DLG4,PRKD1,PRKCA,PRKCB"]
["Neuroinflammation Signaling Pathway",1.96,0.0732,0.229,"GRIN1,GRIN2A,VCAM1,FGFR1,SLC1A3,FGFR2,KCNJ3,MFGE8,FZD1,CX3CR1,FGFR3,FOS,SLC6A11,PLA2G4A,GAD2,JUN,GAB1,GABRG1,CALB2,FGFR4,TGFB2,SLC1A2,GABRA1,ACVR2A"]
["14-3-3-mediated Signaling",1.94,0.0903,0.577,"YAP1,FGFR1,FGFR2,PLCL2,FGFR3,FOS,JUN,FOXO1,GAB1,FGFR4,PRKD1,PRKCB,PRKCA"]
["NF-κB Activation by Viruses",1.92,0.101,0.632,"FGFR3,GAB1,FGFR1,FGFR4,MAP3K1,FGFR2,ITGB5,PRKD1,PRKCA,PRKCB"]
["Salvage Pathways of Pyrimidine Ribonucleotides",1.92,0.0965,-2.111,"MAP2K6,APOBEC3B,APOBEC1,PIM1,AK4,PLK1,NEK2,TTK,CDK2,ACVR2A,CDK1"]
["Signaling by Rho Family GTPases",1.92,0.0766,0.5,"GNG4,PTK2B,PAK6,FGFR1,CDH23,FGFR2,GNA14,GNAZ,CDH11,FGFR3,FOS,JUN,GAB1,RND3,CDH20,EZR,FGFR4,BAIAP2,SEPT10,RHOBTB2"]
["Ethanol Degradation II",1.91,0.136,0,"ALDH1B1,ALDH1L1,ALDH1A3,ACSS1,ACSL1,DHRS4"]
["Mitochondrial L-carnitine Shuttle Pathway",1.91,0.19,0,"ACSBG1,CPT2,ACSL4,ACSL1"]
["ErbB4 Signaling",1.9,0.106,0.707,"FGFR3,YAP1,GAB1,FGFR1,FGFR4,FGFR2,PRKD1,PRKCA,PRKCB"]
["UVA-Induced MAPK Signaling",1.9,0.0957,1.134,"FGFR3,FOS,JUN,GAB1,FGFR1,FGFR4,FGFR2,PLCL2,SMPD3,PARP9,PRKCA"]
["Thrombin Signaling",1.88,0.0786,1.069,"GNG4,ADCY2,CAMK4,FGFR1,FGFR2,PLCL2,GNA14,GNAZ,FGFR3,RND3,GAB1,FGFR4,CAMK1G,RHOBTB2,ADCY8,PRKD1,PRKCA,PRKCB"]
["Gα12/13 Signaling",1.88,0.0884,0.277,"PTK2B,FGFR1,MAP3K1,CDH23,FGFR2,CDH11,FGFR3,JUN,LPAR1,GAB1,FGFR4,VAV3,CDH20"]
["Role of p14/p19ARF in Tumor Suppression",1.87,0.133,0,"FGFR3,GAB1,FGFR1,FGFR4,E2F1,FGFR2"]
["Oxidative Ethanol Degradation III",1.85,0.152,0.447,"ALDH1B1,ALDH1L1,ALDH1A3,ACSS1,ACSL1"]
["Mouse Embryonic Stem Cell Pluripotency",1.84,0.094,0.302,"FGFR3,MYC,FZD8,GAB1,SMAD9,FGFR1,FGFR4,FGFR2,FZD1,FZD2,TCF7L2"]
["FAT10 Cancer Signaling Pathway",1.82,0.13,1.633,"MAD2L1,PCNA,ACKR3,NGFR,TGFB2,ACVR2A"]
["Dermatan Sulfate Biosynthesis",1.8,0.108,0,"CHST2,NDST3,CHSY3,HS6ST2,HS3ST1,NDST4,HS3ST4,HS3ST5"]
["Triacylglycerol Degradation",1.79,0.117,-0.378,"FAAH,NDST3,LPL,PNLIPRP1,LIPG,NDST4,PNLIP"]
["GPCR-Mediated Nutrient Sensing in Enteroendocrine Cells",1.79,0.0924,2.111,"GNG4,ADCY2,CACNB2,RAPGEF4,GNA14,PLCL2,CACNG8,ADCY8,PRKD1,PRKCA,PRKCB"]
["Th2 Pathway",1.76,0.0855,-0.302,"FGFR3,STAT4,CD247,JUN,GAB1,FGFR1,IKZF1,FGFR4,S1PR1,FGFR2,JAG1,TBX21,ACVR2A"]
["Fc Epsilon RI Signaling",1.76,0.0882,0,"FGFR3,SYNJ2,MAP2K6,PLA2G4A,GAB1,FGFR1,FGFR4,VAV3,FGFR2,PRKD1,PRKCA,PRKCB"]
["Pyridoxal 5'-phosphate Salvage Pathway",1.76,0.107,-2.121,"MAP2K6,PIM1,PLK1,TTK,NEK2,ACVR2A,CDK2,CDK1"]
["STAT3 Pathway",1.76,0.0882,0.577,"FGFR3,MYC,IGF1,PIM1,FGFR1,NGFR,FGFR4,HGF,TGFB2,FGFR2,BMPR1B,BMP6"]
["Small Cell Lung Cancer Signaling",1.75,0.1,-0.378,"FGFR3,MYC,GAB1,FGFR1,FGFR4,E2F1,FGFR2,CCND1,CDK2"]
["GDNF Family Ligand-Receptor Interactions",1.75,0.1,1,"FGFR3,FOS,JUN,GAB1,FGFR1,GFRA1,FGFR4,FGFR2,RET"]
["Circadian Rhythm Signaling",1.75,0.143,{"$error":"#NUM!"},"GRIN1,GRIN2A,ADCYAP1R1,BHLHE40,ADCYAP1"]
["Corticotropin Releasing Hormone Signaling",1.74,0.085,1.265,"ADCY2,CAMK4,FOS,JUN,GLI3,NR4A1,CACNB2,CTH,ADCY8,CACNG8,PRKD1,PRKCB,PRKCA"]
["Angiopoietin Signaling",1.72,0.0989,{"$error":"#NUM!"},"FGFR3,ANGPTL1,GRB14,PAK6,GAB1,FOXO1,FGFR1,FGFR4,FGFR2"]
["Natural Killer Cell Signaling",1.72,0.087,{"$error":"#NUM!"},"FGFR3,SYNJ2,CD247,PAK6,GAB1,FGFR1,FGFR4,VAV3,FGFR2,PRKD1,PRKCA,PRKCB"]
["Ethanol Degradation IV",1.7,0.139,0.447,"ALDH1B1,ALDH1L1,ALDH1A3,ACSS1,ACSL1"]
["IL-2 Signaling",1.7,0.104,1.134,"FGFR3,FOS,JUN,PTK2B,GAB1,FGFR1,FGFR4,FGFR2"]
["Androgen Signaling",1.69,0.0863,1.667,"GNG4,AR,JUN,CAMK4,CACNB2,GNAZ,GNA14,CACNG8,CCND1,PRKD1,PRKCA,PRKCB"]
["Sperm Motility",1.69,0.075,1,"MAP2K6,CAMK4,PTK2B,FGFR1,FGFR2,PLCL2,PDE1A,STYK1,FGFR3,PLA2G4A,FGFR4,PDE1B,EPHB3,ERBB2,RET,PRKD1,PRKCA,PRKCB"]
["NRF2-mediated Oxidative Stress Response",1.69,0.0777,0.333,"MAP2K6,FGFR1,MAP3K1,FGFR2,JUNB,MAFF,FGFR3,FOS,JUN,GAB1,FGFR4,ENC1,DNAJB5,PRKD1,PRKCB,PRKCA"]
["Paxillin Signaling",1.67,0.0887,0.707,"FGFR3,PARVA,PTK2B,PAK6,GAB1,FGFR1,FGFR4,ITGA8,FGFR2,ITGA7,ITGB5"]
["dTMP De Novo Biosynthesis",1.67,0.214,{"$error":"#NUM!"},"TYMS,SHMT1,DHFR"]
["Ephrin A Signaling",1.65,0.109,{"$error":"#NUM!"},"FGFR3,GAB1,FGFR4,NGFR,FGFR1,VAV3,FGFR2"]
["Non-Small Cell Lung Cancer Signaling",1.64,0.0957,-0.333,"FGFR3,GAB1,FGFR1,FGFR4,E2F1,FGFR2,ERBB2,CCND1,PRKCA"]
["Estrogen-Dependent Breast Cancer Signaling",1.64,0.0957,0.333,"FGFR3,FOS,JUN,GAB1,IGF1,FGFR1,FGFR4,FGFR2,CCND1"]
["IL-1 Signaling",1.64,0.0957,0,"GNG4,MAP2K6,FOS,ADCY2,JUN,MAP3K1,GNAZ,GNA14,ADCY8"]
["JAK/Stat Signaling",1.64,0.0957,0.333,"FGFR3,STAT4,FOS,JUN,GAB1,FGFR1,FGFR4,FGFR2,CCKBR"]
["Prostate Cancer Signaling",1.63,0.0909,{"$error":"#NUM!"},"FGFR3,AR,GAB1,FOXO1,FGFR1,FGFR4,E2F1,FGFR2,CCND1,CDK2"]
["Pancreatic Adenocarcinoma Signaling",1.63,0.0873,-0.333,"FGFR3,NAPEPLD,GAB1,FGFR1,FGFR4,E2F1,TGFB2,FGFR2,ERBB2,CCND1,CDK2"]
["Renal Cell Carcinoma Signaling",1.61,0.0947,0.333,"FGFR3,FOS,JUN,PAK6,GAB1,FGFR1,FGFR4,HGF,FGFR2"]
["Clathrin-mediated Endocytosis Signaling",1.6,0.0758,{"$error":"#NUM!"},"MYO6,SH3BP4,FGF9,FGFR1,FGFR2,SH3GLB1,SH3GL2,FGFR3,FGF10,GAB1,IGF1,FGFR4,AMPH,SH3KBP1,ITGB5,MYO1E"]
["PPARα/RXRα Activation",1.6,0.0773,0.577,"MAP2K6,ADCY2,IL1RAPL2,GNA14,PLCL2,ACADL,CHD5,JUN,LPL,TGFB2,ADCY8,ACVR2A,ITGB5,PRKCB,PRKCA"]
["Antiproliferative Role of TOB in T Cell Signaling",1.59,0.154,{"$error":"#NUM!"},"CCNA2,CCNA1,TGFB2,CDK2"]
["CD40 Signaling",1.58,0.0988,0,"FGFR3,MAP2K6,FOS,JUN,GAB1,FGFR4,FGFR1,FGFR2"]
["UVC-Induced MAPK Signaling",1.58,0.115,0.816,"FOS,JUN,SMPD3,PRKD1,PRKCB,PRKCA"]
["PTEN Signaling",1.58,0.0859,0.302,"FGFR3,SYNJ2,FOXO4,FOXO1,FGFR1,NGFR,FGFR4,FGFR2,BMPR1B,FOXG1,CCND1"]
["CCR3 Signaling in Eosinophils",1.57,0.0828,0.632,"FGFR3,GNG4,PLA2G4A,CAMK4,PAK6,GAB1,FGFR1,FGFR4,FGFR2,PRKD1,PRKCA,PRKCB"]
["Cell Cycle: G1/S Checkpoint Regulation",1.56,0.104,0.816,"MYC,FOXO1,E2F1,TGFB2,CDKN2C,CCND1,CDK2"]
["Rac Signaling",1.54,0.0846,0.905,"FGFR3,JUN,PTK2B,PAK6,GAB1,FGFR1,FGFR4,BAIAP2,MAP3K1,FGFR2,SH3RF1"]
["Synaptic Long Term Depression",1.53,0.0758,2.138,"GRM8,GRM1,GNAZ,GRM4,GNA14,PLCL2,GRM5,PLA2G4A,IGF1,CACNB2,CTH,CACNG8,PRKD1,PRKCB,PRKCA"]
["3-phosphoinositide Biosynthesis",1.49,0.0734,-1,"CDC25C,PPP1R1B,FGFR1,FGFR2,PAWR,DUSP14,CDC25B,FGFR3,ITPK1,DUSP5,GAB1,PTPRO,PPP1R13B,FGFR4,ERBB2,DUSP16"]
["Endocannabinoid Cancer Inhibition Pathway",1.49,0.0783,-0.277,"MAP2K6,ADCY2,FGFR1,FGFR2,CCND1,MYC,FGFR3,GAB1,FGFR4,ADCY8,SMPD3,TCF7L2,CAMKK2"]
["Mechanisms of Viral Exit from Host Cells",1.48,0.122,{"$error":"#NUM!"},"SH3GLB1,SH3GL2,PRKD1,PRKCB,PRKCA"]
["GM-CSF Signaling",1.47,0.0941,0,"FGFR3,GAB1,PIM1,FGFR1,FGFR4,FGFR2,CCND1,PRKCB"]
["IL-12 Signaling and Production in Macrophages",1.43,0.0789,{"$error":"#NUM!"},"FGFR3,STAT4,FOS,JUN,GAB1,FGFR1,FGFR4,TGFB2,FGFR2,PRKD1,PRKCA,PRKCB"]
["Th1 and Th2 Activation Pathway",1.41,0.0745,{"$error":"#NUM!"},"MAP2K6,CD247,FGFR1,IKZF1,FGFR2,TBX21,FGFR3,STAT4,JUN,GAB1,FGFR4,S1PR1,JAG1,ACVR2A"]
["Apelin Cardiomyocyte Signaling Pathway",1.4,0.0833,1.265,"FGFR3,GAB1,FGFR1,FGFR4,FGFR2,PLCL2,SLC9A2,PRKD1,PRKCA,PRKCB"]
["ILK Signaling",1.38,0.0725,0,"MAP2K6,PARVA,FGFR1,FGFR2,CCND1,FGFR3,MYC,FOS,JUN,RND3,GAB1,FGFR4,MYH3,RHOBTB2,ITGB5"]
["IL-15 Production",1.38,0.0826,{"$error":"#NUM!"},"FGFR3,MAP2K6,PTK2B,FGFR1,FGFR4,FGFR2,EPHB3,ERBB2,RET,STYK1"]
["Amyotrophic Lateral Sclerosis Signaling",1.36,0.082,0.333,"FGFR3,GRIN1,GRIN2A,GAB1,IGF1,NEFL,FGFR1,FGFR4,FGFR2,SLC1A2"]
["Germ Cell-Sertoli Cell Junction Signaling",1.36,0.0733,{"$error":"#NUM!"},"MAP2K6,PAK6,FGFR1,MAP3K1,CTNNA1,FGFR2,PLS1,FGFR3,RND3,GAB1,FGFR4,TGFB2,RHOBTB2,JUP"]
["Cysteine Biosynthesis/Homocysteine Degradation",1.34,0.25,{"$error":"#NUM!"},"CBS/CBSL,CTH"]
["Production of Nitric Oxide and Reactive Oxygen Species in Macrophages",1.34,0.0714,1.069,"PPP1R14C,FGFR1,MAP3K1,FGFR2,FGFR3,FOS,JUN,RND3,GAB1,FGFR4,NGFR,RHOBTB2,PRKD1,PRKCB,PRKCA"]
["Phagosome Formation",1.34,0.0786,{"$error":"#NUM!"},"FGFR3,GAB1,RND3,FGFR1,FGFR4,FGFR2,RHOBTB2,PLCL2,PRKD1,PRKCA,PRKCB"]
["Superpathway of Inositol Phosphate Compounds",1.33,0.0679,-0.471,"CDC25C,PPP1R1B,FGFR1,FGFR2,PAWR,INPP5A,DUSP14,CDC25B,SYNJ2,FGFR3,ITPK1,DUSP5,GAB1,PTPRO,PPP1R13B,FGFR4,ERBB2,DUSP16"]
["TR/RXR Activation",1.33,0.0841,{"$error":"#NUM!"},"FGFR3,ADRB1,CAMK4,GAB1,FGFR1,FGFR4,FGFR2,PFKP,DIO2"]
["Cholecystokinin/Gastrin-mediated Signaling",1.32,0.0806,1,"MAP2K6,FOS,JUN,PTK2B,RND3,RHOBTB2,PRKD1,CCKBR,PRKCA,PRKCB"]
["Docosahexaenoic Acid (DHA) Signaling",1.32,0.1,{"$error":"#NUM!"},"FGFR3,GAB1,FOXO1,FGFR1,FGFR4,FGFR2"]
["IL-23 Signaling Pathway",1.32,0.1,0,"FGFR3,STAT4,GAB1,FGFR1,FGFR4,FGFR2"]
["Fatty Acid Activation",1.31,0.158,{"$error":"#NUM!"},"ACSBG1,ACSL4,ACSL1"]
["Pregnenolone Biosynthesis",1.31,0.158,{"$error":"#NUM!"},"CYP26B1,CYP7B1,MICAL2"]
["RhoA Signaling",1.3,0.08,-1.414,"LPAR1,PTK2B,NRP2,IGF1,RND3,ANLN,EZR,BAIAP2,SEPT10,DLC1"]
["Melanocyte Development and Pigmentation Signaling",1.27,0.0818,1.414,"FGFR3,ADCY2,GAB1,MITF,FGFR1,FGFR4,FGFR2,DCT,ADCY8"]
["Virus Entry via Endocytic Pathways",1.26,0.0787,{"$error":"#NUM!"},"FGFR3,CD55,GAB1,FGFR1,FGFR4,FGFR2,ITGB5,PRKD1,PRKCA,PRKCB"]
["IL-9 Signaling",1.26,0.106,0.447,"FGFR3,GAB1,FGFR1,FGFR4,FGFR2"]
["Role of Wnt/GSK-3β Signaling in the Pathogenesis of Influenza",1.25,0.0897,0,"FZD8,WNT3,WNT7B,FZD1,FZD2,WNT11,TCF7L2"]
["HMGB1 Signaling",1.24,0.0718,0,"MAP2K6,VCAM1,FGFR1,FGFR2,FGFR3,FOS,JUN,RND3,GAB1,NGFR,FGFR4,TGFB2,RHOBTB2"]
["Hepatic Cholestasis",1.24,0.0704,{"$error":"#NUM!"},"CYP7B1,ADCY2,IL1RAPL2,ATP8B1,SLCO1C1,JUN,SLCO3A1,FGFR4,NGFR,TGFB2,ADCY8,PRKD1,PRKCB,PRKCA"]
["VDR/RXR Activation",1.23,0.0886,-1.342,"FOXO1,RUNX2,TGFB2,IGFBP3,PRKD1,PRKCA,PRKCB"]
["TGF-β Signaling",1.21,0.0833,0,"MAP2K6,FOS,JUN,SMAD9,RUNX2,TGFB2,BMPR1B,ACVR2A"]
["Osteoarthritis Pathway",1.21,0.0685,-1.155,"FGFR3,FZD8,TIMP3,H19,GLI3,IL1RAPL2,SMAD9,FRZB,RUNX2,FGFR1,CTNNA1,FZD1,JAG1,FZD2,TCF7L2"]
["Myc Mediated Apoptosis Signaling",1.2,0.0875,{"$error":"#NUM!"},"MYC,FGFR3,GAB1,IGF1,FGFR4,FGFR1,FGFR2"]
["ATM Signaling",1.19,0.0825,0.707,"CDC25C,JUN,SMC2,CCNB2,CDK2,CDK1,CCNB1,CHEK1"]
["Bladder Cancer Signaling",1.19,0.0825,1.342,"MYC,FGFR3,FGF10,FGF9,MMP14,E2F1,ERBB2,CCND1"]
["G Beta Gamma Signaling",1.17,0.0758,1.265,"GNG4,ADCY2,KCNJ3,CACNB2,GNAZ,GNA14,CACNG8,PRKD1,PRKCA,PRKCB"]
["Endocannabinoid Developing Neuron Pathway",1.17,0.0758,-1.265,"FGFR3,MAP2K6,ADCY2,GAB1,FGFR1,FGFR4,FGFR2,PAX6,ADCY8,CCND1"]
["Tight Junction Signaling",1.16,0.0714,{"$error":"#NUM!"},"FOS,JUN,CLDN1,RAB13,NGFR,CTNNA1,MYH3,JAM2,VAMP3,TGFB2,SNAP25,CLDN3"]
["Acetate Conversion to Acetyl-CoA",1.16,0.2,{"$error":"#NUM!"},"ACSS1,ACSL1"]
["Chronic Myeloid Leukemia Signaling",1.15,0.0776,{"$error":"#NUM!"},"FGFR3,MYC,GAB1,FGFR1,FGFR4,E2F1,TGFB2,FGFR2,CCND1"]
["Gap Junction Signaling",1.14,0.067,{"$error":"#NUM!"},"ADCY2,FGFR1,FGFR2,PLCL2,DRD2,FGFR3,ADRB1,LPAR1,GAB1,FGFR4,CTH,ADCY8,PRKD1,PRKCB,PRKCA"]
["Retinol Biosynthesis",1.14,0.098,-2.236,"LPL,PNLIPRP1,LIPG,PNLIP,DHRS4"]
["Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes",1.13,0.08,0,"NAPEPLD,PTK2B,EZR,VAV3,VAMP3,PRKD1,PRKCB,PRKCA"]
["Regulation of Cellular Mechanics by Calpain Protease",1.13,0.0896,0.447,"CCNA2,CCNA1,EZR,CCND1,CDK1,CDK2"]
["Chemokine Signaling",1.11,0.0833,1.89,"FOS,JUN,CAMK4,PTK2B,CAMK1G,PRKCA,PRKCB"]
["GABA Receptor Signaling",1.11,0.0792,{"$error":"#NUM!"},"SLC6A11,ADCY2,GAD2,GABRG1,CACNB2,GABRA1,CACNG8,ADCY8"]
["Thyroid Cancer Signaling",1.11,0.0962,{"$error":"#NUM!"},"MYC,NTF3,RET,CCND1,TCF7L2"]
["Cell Cycle Regulation by BTG Family Proteins",1.1,0.108,-1,"E2F1,BTG2,CCND1,CDK2"]
["Heparan Sulfate Biosynthesis (Late Stages)",1.09,0.0824,-0.378,"CHST2,NDST3,HS6ST2,HS3ST1,NDST4,HS3ST4,HS3ST5"]
["SPINK1 General Cancer Pathway",1.09,0.0824,1.134,"FGFR3,GAB1,FGFR4,FGFR1,FGFR2,Mt2,Mt3"]
["Serotonin Receptor Signaling",1.08,0.0943,{"$error":"#NUM!"},"ADCY2,SLC6A4,HTR1D,SLC18A2,ADCY8"]
["VEGF Signaling",1.08,0.075,0,"FGFR3,PTK2B,GAB1,FOXO1,FGFR1,FGFR4,FGFR2,PRKCA,PRKCB"]
["PKCθ Signaling in T Lymphocytes",1.07,0.069,0.632,"FGFR3,CD247,FOS,JUN,GAB1,FGFR1,FGFR4,VAV3,MAP3K1,FGFR2,CACNB2,CACNG8"]
["Integrin Signaling",1.07,0.0652,0.577,"PARVA,ARHGAP26,TSPAN7,PAK6,FGFR1,ITGA8,FGFR2,FGFR3,RND3,GAB1,FGFR4,RHOBTB2,ITGA7,NEDD9,ITGB5"]
["γ-linolenate Biosynthesis II (Animals)",1.06,0.125,{"$error":"#NUM!"},"ACSBG1,ACSL4,ACSL1"]
["fMLP Signaling in Neutrophils",1.06,0.0719,1,"FGFR3,GNG4,CAMK4,GAB1,FGFR1,FGFR4,FGFR2,PRKD1,PRKCA,PRKCB"]
["CD28 Signaling in T Helper Cells",1.06,0.0719,1,"FGFR3,CD247,FOS,JUN,CAMK4,GAB1,FGFR1,FGFR4,MAP3K1,FGFR2"]
["IL-6 Signaling",1.06,0.0719,0.632,"FGFR3,MAP2K6,FOS,JUN,IL1RAPL2,GAB1,FGFR1,NGFR,FGFR4,FGFR2"]
["Calcium-induced T Lymphocyte Apoptosis",1.06,0.0857,0.816,"CD247,CAMK4,NR4A1,PRKD1,PRKCB,PRKCA"]
["T Cell Exhaustion Signaling Pathway",1.05,0.067,0,"STAT4,FGFR3,FOS,JUN,FOXO1,GAB1,FGFR4,FGFR1,FGFR2,EOMES,BCL6,TBX21,ACVR2A"]
["Transcriptional Regulatory Network in Embryonic Stem Cells",1.05,0.0926,{"$error":"#NUM!"},"RFX4,ISL1,PAX6,OTX1,EOMES"]
["α-Adrenergic Signaling",1.03,0.0762,1.342,"GNG4,ADCY2,CAMK4,ADCY8,PRKD1,ADRA1A,PRKCB,PRKCA"]
["Lymphotoxin β Receptor Signaling",1.03,0.0845,0,"FGFR3,VCAM1,GAB1,FGFR1,FGFR4,FGFR2"]
["Glutamate Degradation III (via 4-aminobutyrate)",1.02,0.167,{"$error":"#NUM!"},"GAD2,SUCLG2"]
["Histidine Degradation VI",1.02,0.12,{"$error":"#NUM!"},"CYP26B1,CYP7B1,MICAL2"]
["Fatty Acid α-oxidation",1.02,0.12,{"$error":"#NUM!"},"ALDH1B1,ALDH1L1,ALDH1A3"]
["RAR Activation",1.01,0.066,{"$error":"#NUM!"},"ADCY2,SMAD9,MAP3K1,FOS,JUN,ALDH1A3,SMARCA2,IGFBP3,TGFB2,ADCY8,PRKD1,PRKCA,PRKCB"]
["Role of IL-17A in Arthritis",1.01,0.0833,{"$error":"#NUM!"},"FGFR3,MAP2K6,GAB1,FGFR1,FGFR4,FGFR2"]
["Inhibition of Matrix Metalloproteases",1.01,0.1,1,"TIMP3,ADAM12,MMP14,TIMP2"]
["Pyrimidine Deoxyribonucleotides De Novo Biosynthesis I",0.979,0.0976,-1,"TYMS,RRM2,AK4,RRM1"]
["1D-myo-inositol Hexakisphosphate Biosynthesis II (Mammalian)",0.979,0.115,{"$error":"#NUM!"},"SYNJ2,ITPK1,INPP5A"]
["Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes",0.971,0.0769,{"$error":"#NUM!"},"CD247,FOS,JUN,CAMK4,VAV3,MAP3K1,TGFB2"]
["Dopamine Receptor Signaling",0.971,0.0769,1,"TH,PPP1R14C,ADCY2,PPP1R1B,SLC18A2,DRD2,ADCY8"]
["BER pathway",0.959,0.154,{"$error":"#NUM!"},"LIG1,PCNA"]
["MSP-RON Signaling Pathway",0.947,0.08,{"$error":"#NUM!"},"FGFR3,GAB1,CSF1,FGFR1,FGFR4,FGFR2"]
["3-phosphoinositide Degradation",0.943,0.0667,-0.905,"SYNJ2,CDC25B,ITPK1,DUSP5,CDC25C,PTPRO,PPP1R1B,PPP1R13B,PAWR,DUSP14,DUSP16"]
["FcγRIIB Signaling in B Lymphocytes",0.917,0.0745,0.447,"FGFR3,GAB1,FGFR4,FGFR1,FGFR2,CACNB2,CACNG8"]
["Antiproliferative Role of Somatostatin Receptor 2",0.917,0.0745,0.447,"FGFR3,GNG4,GAB1,FGFR1,FGFR4,FGFR2,CTH"]
["RhoGDI Signaling",0.917,0.0645,-1.414,"GNG4,PAK6,RND3,CDH20,EZR,CDH23,RHOBTB2,GNAZ,GNA14,DLC1,CDH11,PRKCA"]
["Semaphorin Signaling in Neurons",0.907,0.0833,{"$error":"#NUM!"},"SEMA4D,PAK6,RND3,RHOBTB2,NRP1"]
["Apelin Pancreas Signaling Pathway",0.907,0.0833,0.447,"FGFR3,GAB1,FGFR1,FGFR4,FGFR2"]
["Melatonin Signaling",0.886,0.0769,0.816,"MAP2K6,CAMK4,PLCL2,PRKD1,PRKCB,PRKCA"]
["IL-17 Signaling",0.883,0.0729,{"$error":"#NUM!"},"FGFR3,MAP2K6,JUN,GAB1,FGFR4,FGFR1,FGFR2"]
["PAK Signaling",0.883,0.0702,0.707,"FGFR3,PAK6,PTK2B,GAB1,FGFR1,FGFR4,EPHB3,FGFR2"]
["Heparan Sulfate Biosynthesis",0.883,0.0729,-0.378,"CHST2,NDST3,HS6ST2,HS3ST1,NDST4,HS3ST4,HS3ST5"]
["D-myo-inositol (1,4,5,6)-Tetrakisphosphate Biosynthesis",0.883,0.0662,-1.265,"CDC25B,ITPK1,DUSP5,CDC25C,PTPRO,PPP1R1B,PPP1R13B,PAWR,DUSP14,DUSP16"]
["D-myo-inositol (3,4,5,6)-tetrakisphosphate Biosynthesis",0.883,0.0662,-1.265,"CDC25B,ITPK1,DUSP5,CDC25C,PTPRO,PPP1R1B,PPP1R13B,PAWR,DUSP14,DUSP16"]
["Fatty Acid β-oxidation I",0.866,0.0889,0,"ACSBG1,ACSL4,HADH,ACSL1"]
["SAPK/JNK Signaling",0.854,0.069,0,"FGFR3,JUN,GAB1,FGFR1,FGFR4,MAP3K1,FGFR2,DUSP4"]
["TNFR2 Signaling",0.842,0.1,{"$error":"#NUM!"},"FOS,JUN,MAP3K1"]
["nNOS Signaling in Skeletal Muscle Cells",0.842,0.087,{"$error":"#NUM!"},"SNTB2,CAMK4,CACNB2,CACNG8"]
["Role of JAK1 and JAK3 in γc Cytokine Signaling",0.833,0.0741,{"$error":"#NUM!"},"FGFR3,GAB1,PTK2B,FGFR1,FGFR4,FGFR2"]
["Insulin Receptor Signaling",0.818,0.0641,0,"FGFR3,SYNJ2,PPP1R14C,FOXO4,GAB1,FOXO1,FGFR1,FGFR4,FGFR2,GRB10"]
["Sonic Hedgehog Signaling",0.81,0.0968,{"$error":"#NUM!"},"GLI3,CDK1,CCNB1"]
["Th1 Pathway",0.807,0.0652,-0.333,"FGFR3,STAT4,MAP2K6,CD247,GAB1,FGFR1,FGFR4,FGFR2,TBX21"]
["Wnt/Ca+ pathway",0.801,0.0769,0.447,"FZD8,PLCL2,FZD1,FZD2,PRKCA"]
["Glutamate Dependent Acid Resistance",0.783,0.25,{"$error":"#NUM!"},"GAD2"]
["tRNA Splicing",0.772,0.0816,-1,"SMPDL3A,NAPEPLD,PDE1B,PDE1A"]
["Telomerase Signaling",0.767,0.0656,0.378,"MYC,FGFR3,GAB1,FGFR1,FGFR4,E2F1,FGFR2,ELK3"]
["Ubiquinol-10 Biosynthesis (Eukaryotic)",0.752,0.0909,{"$error":"#NUM!"},"CYP26B1,CYP7B1,MICAL2"]
["Histamine Degradation",0.752,0.0909,{"$error":"#NUM!"},"ALDH1B1,ALDH1L1,ALDH1A3"]
["TNFR1 Signaling",0.75,0.08,1,"FOS,JUN,PAK6,MAP3K1"]
["Role of NFAT in Regulation of the Immune Response",0.738,0.0594,0.302,"FGFR3,GNG4,CD247,FOS,JUN,CAMK4,GAB1,FGFR1,FGFR4,FGFR2,GNAZ,GNA14"]
["Tryptophan Degradation to 2-amino-3-carboxymuconate Semialdehyde",0.728,0.111,{"$error":"#NUM!"},"TDO2,IDO2"]
["Aldosterone Signaling in Epithelial Cells",0.721,0.0598,1,"FGFR3,CRYAB,GAB1,FGFR1,FGFR4,FGFR2,PLCL2,PRKD1,DNAJB5,PRKCA,PRKCB"]
["IL-15 Signaling",0.717,0.0682,{"$error":"#NUM!"},"FGFR3,VCAM1,GAB1,FGFR1,FGFR4,FGFR2"]
["NER Pathway",0.714,0.0654,-2.449,"LIG1,PCNA,RFC4,POLE2,TOP2A,POLD1,CHAF1A"]
["Netrin Signaling",0.708,0.0714,{"$error":"#NUM!"},"ABLIM3,CACNB2,ABLIM2,CACNG8,ABLIM1"]
["Tryptophan Degradation X (Mammalian, via Tryptamine)",0.701,0.0857,{"$error":"#NUM!"},"ALDH1B1,ALDH1L1,ALDH1A3"]
["Putrescine Degradation III",0.701,0.0857,{"$error":"#NUM!"},"ALDH1B1,ALDH1L1,ALDH1A3"]
["Asparagine Degradation I",0.695,0.2,{"$error":"#NUM!"},"ASRGL1"]
["Anandamide Degradation",0.695,0.2,{"$error":"#NUM!"},"FAAH"]
["L-cysteine Degradation II",0.695,0.2,{"$error":"#NUM!"},"CTH"]
["Glutamine Degradation I",0.695,0.2,{"$error":"#NUM!"},"GLS2"]
["Superpathway of Serine and Glycine Biosynthesis I",0.693,0.105,{"$error":"#NUM!"},"PHGDH,SHMT1"]
["CD27 Signaling in Lymphocytes",0.688,0.0755,{"$error":"#NUM!"},"MAP2K6,FOS,JUN,MAP3K1"]
["Sumoylation Pathway",0.686,0.0642,0,"FOS,PCNA,AR,JUN,RFC4,RND3,RHOBTB2"]
["Cardiac β-adrenergic Signaling",0.684,0.0608,-0.707,"GNG4,SMPDL3A,PPP1R14C,NAPEPLD,ADCY2,ADRB1,PDE1B,ADCY8,PDE1A"]
["p70S6K Signaling",0.674,0.0604,1,"FGFR3,GAB1,FGFR1,FGFR4,FGFR2,PLCL2,PRKD1,PRKCA,PRKCB"]
["Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses",0.672,0.0592,0.707,"FGFR3,PTX3,GAB1,FGFR1,FGFR4,TGFB2,FGFR2,PRKD1,PRKCA,PRKCB"]
["D-myo-inositol-5-phosphate Metabolism",0.672,0.0592,-1.265,"CDC25B,ITPK1,DUSP5,CDC25C,PTPRO,PPP1R1B,PPP1R13B,PAWR,DUSP14,DUSP16"]
["Noradrenaline and Adrenaline Degradation",0.67,0.0741,0,"ALDH1B1,ALDH1L1,ALDH1A3,DHRS4"]
["Caveolar-mediated Endocytosis Signaling",0.66,0.0685,{"$error":"#NUM!"},"CD55,ITGA8,ITGA7,ITGB5,PRKCA"]
["Gαs Signaling",0.66,0.0631,0.816,"GNG4,ADCY2,ADRB1,RAPGEF4,ADCY8,CHRM1,MC4R"]
["Cardiomyocyte Differentiation via BMP Receptors",0.658,0.1,{"$error":"#NUM!"},"BMPR1B,BMP5"]
["Salvage Pathways of Pyrimidine Deoxyribonucleotides",0.658,0.1,{"$error":"#NUM!"},"APOBEC3B,TK1"]
["CDK5 Signaling",0.648,0.0625,0.378,"PPP1R14C,LAMA5,ADCY2,PPP1R1B,NGFR,EGR1,ADCY8"]
["CNTF Signaling",0.644,0.0676,0.447,"FGFR3,GAB1,FGFR1,FGFR4,FGFR2"]
["Ephrin B Signaling",0.644,0.0676,0,"GNG4,VAV3,EPHB3,GNAZ,GNA14"]
["FAK Signaling",0.635,0.0619,{"$error":"#NUM!"},"FGFR3,ARHGAP26,PAK6,GAB1,FGFR1,FGFR4,FGFR2"]
["Glycine Biosynthesis I",0.625,0.167,{"$error":"#NUM!"},"SHMT1"]
["L-serine Degradation",0.625,0.167,{"$error":"#NUM!"},"SDSL"]
["NGF Signaling",0.62,0.0597,1.414,"FGFR3,GAB1,NGFR,FGFR1,FGFR4,MAP3K1,FGFR2,SMPD3"]
["FLT3 Signaling in Hematopoietic Progenitor Cells",0.616,0.0632,0,"FGFR3,STAT4,GAB1,FGFR1,FGFR4,FGFR2"]
["April Mediated Signaling",0.609,0.0769,{"$error":"#NUM!"},"FOS,JUN,MAP3K1"]
["Epithelial Adherens Junction Signaling",0.609,0.0581,{"$error":"#NUM!"},"FGFR1,HGF,BAIAP2,CTNNA1,MYH3,TGFB2,JUP,ACVR2A,TCF7L2"]
["D-myo-inositol (1,4,5)-trisphosphate Degradation",0.597,0.0909,{"$error":"#NUM!"},"SYNJ2,INPP5A"]
["Apelin Cardiac Fibroblast Signaling Pathway",0.597,0.0909,{"$error":"#NUM!"},"CTGF,TGFB2"]
["PEDF Signaling",0.578,0.0612,0,"FGFR3,GAB1,FGFR1,FGFR4,FGFR2,TCF7L2"]
["p38 MAPK Signaling",0.577,0.0593,-0.816,"MAP2K6,MYC,CDC25B,PLA2G4A,TIFA,IL1RAPL2,TGFB2"]
["B Cell Activating Factor Signaling",0.569,0.0732,{"$error":"#NUM!"},"FOS,JUN,MAP3K1"]
["Dermatan Sulfate Degradation (Metazoa)",0.569,0.087,{"$error":"#NUM!"},"FGFRL1,CEMIP"]
["Glycine Betaine Degradation",0.569,0.087,{"$error":"#NUM!"},"SHMT1,SDSL"]
["Choline Degradation I",0.567,0.143,{"$error":"#NUM!"},"CHDH"]
["Thiosulfate Disproportionation III (Rhodanese)",0.567,0.143,{"$error":"#NUM!"},"TST"]
["Role of BRCA1 in DNA Damage Response",0.556,0.0625,{"$error":"#NUM!"},"RFC4,SMARCA2,E2F1,PLK1,CHEK1"]
["Gustation Pathway",0.551,0.0559,{"$error":"#NUM!"},"SMPDL3A,NAPEPLD,ADCY2,PDE1B,P2RY12,CACNB2,CACNG8,ADCY8,PDE1A"]
["Glycolysis I",0.55,0.0714,{"$error":"#NUM!"},"ENO4,PFKP,ALDOC"]
["D-myo-inositol (1,3,4)-trisphosphate Biosynthesis",0.544,0.0833,{"$error":"#NUM!"},"SYNJ2,INPP5A"]
["Neuregulin Signaling",0.542,0.0594,0.816,"MYC,DLG4,ERBB2,PRKD1,PRKCB,PRKCA"]
["CTLA4 Signaling in Cytotoxic T Lymphocytes",0.542,0.0594,{"$error":"#NUM!"},"FGFR3,CD247,GAB1,FGFR1,FGFR4,FGFR2"]
["IL-4 Signaling",0.542,0.0594,{"$error":"#NUM!"},"FGFR3,SYNJ2,GAB1,FGFR1,FGFR4,FGFR2"]
["Role of PI3K/AKT Signaling in the Pathogenesis of Influenza",0.53,0.061,0.447,"FGFR3,GAB1,FGFR1,FGFR4,FGFR2"]
["IL-17A Signaling in Airway Cells",0.53,0.061,0.447,"FGFR3,GAB1,FGFR1,FGFR4,FGFR2"]
["Cellular Effects of Sildenafil (Viagra)",0.519,0.0556,{"$error":"#NUM!"},"ADCY2,CAMK4,PDE1B,MYH3,PLCL2,CACNG8,ADCY8,PDE1A"]
["IL-17A Signaling in Gastric Cells",0.519,0.08,{"$error":"#NUM!"},"FOS,JUN"]
["Asparagine Biosynthesis I",0.519,0.125,{"$error":"#NUM!"},"ASNS"]
["MIF Regulation of Innate Immunity",0.496,0.0667,{"$error":"#NUM!"},"FOS,PLA2G4A,JUN"]
["NF-κB Signaling",0.483,0.0526,0.632,"FGFR3,MAP2K6,GAB1,FGFR1,NGFR,FGFR4,MAP3K1,FGFR2,BMPR1B,PRKCB"]
["HIPPO signaling",0.481,0.0581,{"$error":"#NUM!"},"PPP1R14C,YAP1,WWC1,DLG4,TEAD2"]
["Role of Oct4 in Mammalian Embryonic Stem Cell Pluripotency",0.48,0.0652,{"$error":"#NUM!"},"CCNF,SH3GLB1,SALL4"]
["Thioredoxin Pathway",0.476,0.111,{"$error":"#NUM!"},"NXN"]
["1D-myo-inositol Hexakisphosphate Biosynthesis V (from Ins(1,3,4)P3)",0.476,0.111,{"$error":"#NUM!"},"ITPK1"]
["Citrulline Biosynthesis",0.474,0.0741,{"$error":"#NUM!"},"OAT,GLS2"]
["Calcium Signaling",0.462,0.0514,2.828,"GRIN1,GRIN2A,CAMK4,ATP2B1,MYH3,CAMK1G,CACNB2,TRPC5,CACNG8,CAMKK2,TRPC7"]
["iCOS-iCOSL Signaling in T Helper Cells",0.456,0.0538,0.816,"FGFR3,CD247,CAMK4,GAB1,FGFR4,FGFR1,FGFR2"]
["iNOS Signaling",0.449,0.0625,{"$error":"#NUM!"},"FOS,JUN,CAMK4"]
["HIF1α Signaling",0.447,0.0534,{"$error":"#NUM!"},"FGFR3,JUN,GAB1,FGFR4,FGFR1,MMP14,FGFR2"]
["Actin Cytoskeleton Signaling",0.445,0.0504,0.632,"FGFR3,FGF10,PAK6,GAB1,FGFR1,EZR,FGFR4,FGF9,VAV3,BAIAP2,MYH3,FGFR2"]
["Embryonic Stem Cell Differentiation into Cardiac Lineages",0.44,0.1,{"$error":"#NUM!"},"ISL1"]
["4-aminobutyrate Degradation I",0.44,0.1,{"$error":"#NUM!"},"SUCLG2"]
["Tryptophan Degradation III (Eukaryotic)",0.42,0.06,{"$error":"#NUM!"},"TDO2,IDO2,HADH"]
["Dopamine Degradation",0.407,0.0588,{"$error":"#NUM!"},"ALDH1B1,ALDH1L1,ALDH1A3"]
["Reelin Signaling in Neurons",0.398,0.0532,{"$error":"#NUM!"},"FGFR3,GAB1,FGFR1,FGFR4,FGFR2"]
["IL-10 Signaling",0.395,0.0548,{"$error":"#NUM!"},"MAP2K6,FOS,JUN,IL1RAPL2"]
["ERK5 Signaling",0.395,0.0548,0,"MYC,CTF1,FOS,GAB1"]
["Granulocyte Adhesion and Diapedesis",0.393,0.0497,{"$error":"#NUM!"},"VCAM1,IL1RAPL2,CLDN1,NGFR,EZR,MMP14,THY1,CLDN3,SELPLG"]
["T Helper Cell Differentiation",0.384,0.0541,{"$error":"#NUM!"},"STAT4,NGFR,BCL6,TBX21"]
["The Visual Cycle",0.382,0.0625,{"$error":"#NUM!"},"RLBP1,DHRS4"]
["Superpathway of D-myo-inositol (1,4,5)-trisphosphate Metabolism",0.382,0.0625,{"$error":"#NUM!"},"SYNJ2,INPP5A"]
["mTOR Signaling",0.379,0.0485,0.632,"FGFR3,NAPEPLD,GAB1,RND3,FGFR1,FGFR4,FGFR2,RHOBTB2,PRKD1,PRKCA,PRKCB"]
["Hematopoiesis from Multipotent Stem Cells",0.379,0.0833,{"$error":"#NUM!"},"CSF1"]
["Eumelanin Biosynthesis",0.379,0.0833,{"$error":"#NUM!"},"DCT"]
["Phospholipases",0.374,0.0533,-1,"PLA2G4A,NAPEPLD,LIPG,PLCL2"]
["Toll-like Receptor Signaling",0.354,0.0519,{"$error":"#NUM!"},"MAP2K6,FOS,JUN,MAP3K1"]
["PI3K Signaling in B Lymphocytes",0.353,0.049,1.134,"FOS,JUN,CAMK4,DAPP1,VAV3,PLCL2,PRKCB"]
["Chondroitin and Dermatan Biosynthesis",0.353,0.0769,{"$error":"#NUM!"},"CHSY3"]
["Thyronamine and Iodothyronamine Metabolism",0.353,0.0769,{"$error":"#NUM!"},"DIO2"]
["Glycine Cleavage Complex",0.353,0.0769,{"$error":"#NUM!"},"GLDC"]
["Thyroid Hormone Metabolism I (via Deiodination)",0.353,0.0769,{"$error":"#NUM!"},"DIO2"]
["Arginine Degradation I (Arginase Pathway)",0.353,0.0769,{"$error":"#NUM!"},"OAT"]
["NAD biosynthesis II (from tryptophan)",0.351,0.0588,{"$error":"#NUM!"},"TDO2,IDO2"]
["IL-17A Signaling in Fibroblasts",0.336,0.0571,{"$error":"#NUM!"},"FOS,JUN"]
["DNA Double-Strand Break Repair by Homologous Recombination",0.33,0.0714,{"$error":"#NUM!"},"LIG1"]
["Serine Biosynthesis",0.33,0.0714,{"$error":"#NUM!"},"PHGDH"]
["Calcium Transport I",0.33,0.0714,{"$error":"#NUM!"},"ATP2B1"]
["Stearate Biosynthesis I (Animals)",0.324,0.0517,{"$error":"#NUM!"},"ACSBG1,ACSL4,ACSL1"]
["CDP-diacylglycerol Biosynthesis I",0.323,0.0556,{"$error":"#NUM!"},"CDS1,MBOAT1"]
["Sertoli Cell-Sertoli Cell Junction Signaling",0.313,0.0464,{"$error":"#NUM!"},"MPP6,JUN,CLDN1,MAP3K1,CTNNA1,JAM2,JUP,CLDN3,PLS1"]
["Cysteine Biosynthesis III (mammalia)",0.31,0.0541,{"$error":"#NUM!"},"CBS/CBSL,CTH"]
["Catecholamine Biosynthesis",0.308,0.0667,{"$error":"#NUM!"},"TH"]
["Sphingomyelin Metabolism",0.308,0.0667,{"$error":"#NUM!"},"SMPD3"]
["Nur77 Signaling in T Lymphocytes",0.304,0.05,{"$error":"#NUM!"},"CD247,CAMK4,NR4A1"]
["Phospholipase C Signaling",0.298,0.0453,0.816,"GNG4,CD247,PLA2G4A,NAPEPLD,ADCY2,CAMK4,RND3,RHOBTB2,ADCY8,PRKD1,PRKCA,PRKCB"]
["Retinoate Biosynthesis I",0.298,0.0526,{"$error":"#NUM!"},"ALDH1A3,DHRS4"]
["Complement System",0.298,0.0526,{"$error":"#NUM!"},"CD55,SERPING1"]
["Dendritic Cell Maturation",0.297,0.0457,1,"FGFR3,STAT4,GAB1,FGFR1,NGFR,FGFR4,FGFR2,CD83,PLCL2"]
["Arginine Degradation VI (Arginase 2 Pathway)",0.289,0.0625,{"$error":"#NUM!"},"OAT"]
["Superpathway of Citrulline Metabolism",0.286,0.0513,{"$error":"#NUM!"},"OAT,GLS2"]
["Cancer Drug Resistance By Drug Efflux",0.259,0.0462,{"$error":"#NUM!"},"FOXO4,FOXO1,FOXG1"]
["Folate Polyglutamylation",0.255,0.0556,{"$error":"#NUM!"},"SHMT1"]
["Phosphatidylglycerol Biosynthesis II (Non-plastidic)",0.253,0.0476,{"$error":"#NUM!"},"CDS1,MBOAT1"]
["Oncostatin M Signaling",0.243,0.0465,{"$error":"#NUM!"},"TIMP3,CHI3L1"]
["RAN Signaling",0.24,0.0526,{"$error":"#NUM!"},"KPNA2"]
["Proline Biosynthesis II (from Arginine)",0.24,0.0526,{"$error":"#NUM!"},"OAT"]
["Sucrose Degradation V (Mammalian)",0.24,0.0526,{"$error":"#NUM!"},"ALDOC"]
["Lysine Degradation II",0.24,0.0526,{"$error":"#NUM!"},"AASS"]
["Granzyme A Signaling",0.226,0.05,{"$error":"#NUM!"},"HMGB2"]
["BAG2 Signaling Pathway",0.225,0.0444,{"$error":"#NUM!"},"MYC,BAG2"]
["Zymosterol Biosynthesis",0.201,0.0455,{"$error":"#NUM!"},"LBR"]
["Inflammasome pathway",0.201,0.0455,{"$error":"#NUM!"},"NEK7"]
["Glucocorticoid Receptor Signaling",0,0.0421,{"$error":"#NUM!"},"CD247,VCAM1,FGFR1,MAP3K1,PBX1,FGFR2,FGFR3,FOS,JUN,AR,PCK2,GAB1,SMARCA2,FGFR4,TGFB2"]
["Acute Phase Response Signaling",0,0.0331,0.447,"MAP2K6,FOS,SERPING1,JUN,NGFR,MAP3K1"]
["LXR/RXR Activation",0,0.0312,{"$error":"#NUM!"},"IL1RAPL2,NGFR,LPL,HADH"]
["FXR/RXR Activation",0,0.0292,{"$error":"#NUM!"},"PCK2,FOXO1,FGFR4,LPL"]
["PXR/RXR Activation",0,0.0429,{"$error":"#NUM!"},"PCK2,FOXO1,ABCB9"]
["Regulation of Actin-based Motility by Rho",0,0.0417,{"$error":"#NUM!"},"PAK6,RND3,BAIAP2,RHOBTB2"]
["Activation of IRF by Cytosolic Pattern Recognition Receptors",0,0.0159,{"$error":"#NUM!"},"JUN"]
["Role of PKR in Interferon Induction and Antiviral Response",0,0.0244,{"$error":"#NUM!"},"MAP2K6"]
["TREM1 Signaling",0,0.0132,{"$error":"#NUM!"},"CD83"]
["Cytotoxic T Lymphocyte-mediated Apoptosis of Target Cells",0,0.0312,{"$error":"#NUM!"},"CD247"]
["4-1BB Signaling in T Lymphocytes",0,0.0312,{"$error":"#NUM!"},"JUN"]
["Induction of Apoptosis by HIV1",0,0.0328,{"$error":"#NUM!"},"SLC25A13,NGFR"]
["Agrin Interactions at Neuromuscular Junction",0,0.038,{"$error":"#NUM!"},"JUN,PAK6,ERBB2"]
["Polyamine Regulation in Colon Cancer",0,0.0435,{"$error":"#NUM!"},"MYC"]
["Type I Diabetes Mellitus Signaling",0,0.0357,{"$error":"#NUM!"},"MAP2K6,CD247,GAD2,NGFR"]
["G Protein Signaling Mediated by Tubby",0,0.0294,{"$error":"#NUM!"},"GNG4"]
["Communication between Innate and Adaptive Immune Cells",0,0.0103,{"$error":"#NUM!"},"CD83"]
["Crosstalk between Dendritic Cells and Natural Killer Cells",0,0.0111,{"$error":"#NUM!"},"CD83"]
["Systemic Lupus Erythematosus Signaling",0,0.037,{"$error":"#NUM!"},"FGFR3,CD247,FOS,JUN,CAMK4,GAB1,FGFR1,FGFR4,FGFR2"]
["Cdc42 Signaling",0,0.0237,-1,"CD247,FOS,JUN,BAIAP2"]
["EIF2 Signaling",0,0.0298,-0.378,"MYC,FGFR3,GAB1,FGFR1,FGFR4,FGFR2,CCND1"]
["Retinoic acid Mediated Apoptosis Signaling",0,0.0159,{"$error":"#NUM!"},"PARP9"]
["Altered T Cell and B Cell Signaling in Rheumatoid Arthritis",0,0.0111,{"$error":"#NUM!"},"CSF1"]
["Atherosclerosis Signaling",0,0.0388,{"$error":"#NUM!"},"PLA2G4A,VCAM1,CSF1,LPL,SELPLG"]
["Regulation of eIF4 and p70S6K Signaling",0,0.0291,0.447,"FGFR3,GAB1,FGFR1,FGFR4,FGFR2"]
["Neuroprotective Role of THOP1 in Alzheimer's Disease",0,0.00794,{"$error":"#NUM!"},"PRSS12"]
["Role of Lipids/Lipid Rafts in the Pathogenesis of Influenza",0,0.0417,{"$error":"#NUM!"},"RSAD2"]
["Role of MAPK Signaling in the Pathogenesis of Influenza",0,0.0353,{"$error":"#NUM!"},"MAP2K6,PLA2G4A,PRKCA"]
["OX40 Signaling Pathway",0,0.0222,{"$error":"#NUM!"},"CD247,JUN"]
["Inhibition of Angiogenesis by TSP1",0,0.0256,{"$error":"#NUM!"},"JUN"]
["MIF-mediated Glucocorticoid Regulation",0,0.0278,{"$error":"#NUM!"},"PLA2G4A"]
["Role of IL-17F in Allergic Inflammatory Airway Diseases",0,0.0222,{"$error":"#NUM!"},"IGF1"]
["Actin Nucleation by ARP-WASP Complex",0,0.0417,{"$error":"#NUM!"},"RND3,BAIAP2,RHOBTB2"]
["Hematopoiesis from Pluripotent Stem Cells",0,0.0408,{"$error":"#NUM!"},"CD247,CSF1"]
["Thyroid Hormone Metabolism II (via Conjugation and/or Degradation)",0,0.0156,{"$error":"#NUM!"},"DIO2"]
["Arginine Biosynthesis IV",0,0.0417,{"$error":"#NUM!"},"OAT"]
["Chondroitin Sulfate Degradation (Metazoa)",0,0.0435,{"$error":"#NUM!"},"CEMIP"]
["Pyrimidine Ribonucleotides De Novo Biosynthesis",0,0.0294,{"$error":"#NUM!"},"ENTPD3,AK4"]
["Glutaryl-CoA Degradation",0,0.037,{"$error":"#NUM!"},"HADH"]
["Choline Biosynthesis III",0,0.0417,{"$error":"#NUM!"},"NAPEPLD"]
["Cholesterol Biosynthesis I",0,0.025,{"$error":"#NUM!"},"LBR"]
["Glutathione-mediated Detoxification",0,0.0227,{"$error":"#NUM!"},"Gsta4"]
["Serotonin Degradation",0,0.044,0,"ALDH1B1,ALDH1L1,ALDH1A3,DHRS4"]
["Triacylglycerol Biosynthesis",0,0.0167,{"$error":"#NUM!"},"MBOAT1"]
["Pyrimidine Ribonucleotides Interconversion",0,0.0364,{"$error":"#NUM!"},"ENTPD3,AK4"]
["Purine Nucleotides De Novo Biosynthesis II",0,0.0244,{"$error":"#NUM!"},"ADSSL1"]
["Cholesterol Biosynthesis II (via 24,25-dihydrolanosterol)",0,0.025,{"$error":"#NUM!"},"LBR"]
["Gluconeogenesis I",0,0.0426,{"$error":"#NUM!"},"ENO4,ALDOC"]
["Cholesterol Biosynthesis III (via Desmosterol)",0,0.025,{"$error":"#NUM!"},"LBR"]
["Superpathway of Methionine Degradation",0,0.0282,{"$error":"#NUM!"},"CBS/CBSL,CTH"]
["Folate Transformations I",0,0.0357,{"$error":"#NUM!"},"SHMT1"]
["Superpathway of Cholesterol Biosynthesis",0,0.0118,{"$error":"#NUM!"},"LBR"]
["Antioxidant Action of Vitamin C",0,0.0342,{"$error":"#NUM!"},"PLA2G4A,NAPEPLD,PLCL2,NXN"]
["Remodeling of Epithelial Adherens Junctions",0,0.029,{"$error":"#NUM!"},"HGF,CTNNA1"]
["Agranulocyte Adhesion and Diapedesis",0,0.0363,{"$error":"#NUM!"},"VCAM1,CLDN1,EZR,MMP14,MYH3,CLDN3,SELPLG"]
["Vitamin-C Transport",0,0.0435,{"$error":"#NUM!"},"NXN"]
["Unfolded protein response",0,0.0179,{"$error":"#NUM!"},"EDEM1"]
["Estrogen Receptor Signaling",0,0.0219,{"$error":"#NUM!"},"PCK2,RUNX2,NR0B1"]
["PI3K/AKT Signaling",0,0.0292,{"$error":"#NUM!"},"SYNJ2,GAB1,FOXO1,CCND1"]
["Protein Ubiquitination Pathway",0,0.0218,{"$error":"#NUM!"},"CRYAB,CDC20,USP43,USP1,DNAJB5,UBE2C"]
["Death Receptor Signaling",0,0.011,{"$error":"#NUM!"},"PARP9"]
["PPAR Signaling",0,0.0385,-1,"FOS,JUN,IL1RAPL2,NGFR"]
["Apoptosis Signaling",0,0.0202,{"$error":"#NUM!"},"CDK1,PRKCA"]
["Hypoxia Signaling in the Cardiovascular System",0,0.027,{"$error":"#NUM!"},"JUN,UBE2C"]
["Phagosome Maturation",0,0.0258,{"$error":"#NUM!"},"CTSO,VAMP3,SNAP25,ATP6V0E1"]
["Autophagy",0,0.0154,{"$error":"#NUM!"},"CTSO"]
["Sirtuin Signaling Pathway",0,0.0277,0,"MYC,FOXO4,ACADL,JUN,PCK2,FOXO1,DUSP6,E2F1,AGTRAP"]
["Iron homeostasis signaling pathway",0,0.0329,{"$error":"#NUM!"},"CYBRD1,BMPR1B,BMP6,BMP5,ATP6V0E1"]
["Th17 Activation Pathway",0,0.0215,{"$error":"#NUM!"},"STAT4,AHR"]
["SPINK1 Pancreatic Cancer Pathway",0,0.0167,{"$error":"#NUM!"},"CPA4"]
["Apelin Adipocyte Signaling Pathway",0,0.025,{"$error":"#NUM!"},"ADCY2,ADCY8"]
["PFKFB4 Signaling Pathway",0,0.0323,{"$error":"#NUM!"},"MAP2K6,TGFB2"]
["Eicosanoid Signaling",0,0.0116,{"$error":"#NUM!"},"PLA2G4A"]
["Ephrin Receptor Signaling",0,0.0383,1.633,"GNG4,GRIN1,GRIN2A,PAK6,EPHB3,GNA14,GNAZ"]

{"sheet":"Axon guidance signaling","index":1,"n_rows":52,"n_cols":15,"rows_kept":52,"flags":["formulas_cached_only"]}
["© 2000-2019 QIAGEN. All rights reserved."]
["Symbol","Entrez Gene Name","Gene Symbol - mouse (Entrez Gene)","Expr Fold Change","Expr Log Ratio","Expr p-value","Expr False Discovery Rate (q-value)","Expected","Location","Type(s)","Biomarker Application(s)","Drug(s)","Entrez Gene ID for Human","Entrez Gene ID for Mouse","Entrez Gene ID for Rat"]
["ABLIM1","actin binding LIM protein 1","Ablim1",2.115,1.081,1.03e-12,1.44e-10," ","Cytoplasm","other",null,null,3983,226251,307989]
["ABLIM2","actin binding LIM protein family member 2","Ablim2",1.441,0.527,0.000922,0.0161," ","Cytoplasm","other",null,null,84448,231148,360958]
["ABLIM3","actin binding LIM protein family member 3","Ablim3",1.304,0.383,0.00133,0.0217," ","Cytoplasm","other",null,null,22885,319713,307395]
["ADAM12","ADAM metallopeptidase domain 12","Adam12",2.005,1.003,0.000488,0.00945," ","Plasma Membrane","peptidase","diagnosis",null,8038,11489,679837]
["ADAMTS1","ADAM metallopeptidase with thrombospondin type 1 motif 1","Adamts1",-1.776,-0.829,2.7e-07,1.54e-05," ","Extracellular Space","peptidase",null,null,9510,11504,79252]
["ADAMTS2","ADAM metallopeptidase with thrombospondin type 1 motif 2","Adamts2",-1.646,-0.719,0.000607,0.0113," ","Extracellular Space","peptidase","diagnosis,efficacy",null,9509,216725,287899]
["ADAMTS17","ADAM metallopeptidase with thrombospondin type 1 motif 17","Adamts17",-1.825,-0.868,6.17e-05,0.00173," ","Extracellular Space","other",null,null,170691,233332,293004]
["ADAMTS20","ADAM metallopeptidase with thrombospondin type 1 motif 20","Adamts20",1.541,0.624,0.00228,0.0333," ","Extracellular Space","peptidase",null,null,80070,223838,315263]
["BAIAP2","BAI1 associated protein 2","Baiap2",-1.464,-0.55,9.03e-05,0.00238," ","Plasma Membrane","kinase",null,null,10458,108100,117542]
["BMP5","bone morphogenetic protein 5","Bmp5",2.27,1.183,0.00245,0.0353," ","Extracellular Space","growth factor",null,null,653,12160,315824]
["BMP6","bone morphogenetic protein 6","Bmp6",5.52,2.465,9.66e-11,1.05e-08," ","Extracellular Space","growth factor",null,null,654,12161,25644]
["EPHB3","EPH receptor B3","Ephb3",-1.378,-0.462,0.000239,0.00536," ","Plasma Membrane","kinase",null,null,2049,13845,287989]
["ERBB2","erb-b2 receptor tyrosine kinase 2","Erbb2",-1.558,-0.639,4.97e-05,0.00144," ","Plasma Membrane","kinase","diagnosis,disease progression,efficacy,prognosis,safety,unspecified application","68GaNOTA-anti-HER2 VHH1,89Zr-trastuzumab,[68Ga]ABY-025,A166,ADCT-502,afatinib,afatinib/cetuximab,afatinib/osimertinib,afatinib/paclitaxel,allitinib,anastrozole/lapatinib,anastrozole/lapatinib/trastuzumab,anastrozole/pertuzumab/trastuzumab,anastrozole/trastuzumab,anti-HER2 antibody,AP32788,ARX788,BMS-599626,BMS-690514,BTRC4017A,capecitabine/docetaxel/oxaliplatin/trastuzumab,capecitabine/lapatinib,capecitabine/pertuzumab/trastuzumab,capecitabine/trastuzumab,CP-724,714,CUDC 101,cyclophosphamide/docetaxel/doxorubicin/pertuzumab/trastuzumab,cyclophosphamide/docetaxel/doxorubicin/trastuzumab,cyclophosphamide/docetaxel/epirubicin/5-fluorouracil/trastuzumab,cyclophosphamide/docetaxel/trastuzumab,cyclophosphamide/doxorubicin/paclitaxel/pertuzumab/trastuzumab,cyclophosphamide/doxorubicin/paclitaxel/trastuzumab,cyclophosphamide/doxorubicin/trastuzumab,cyclophosphamide/epirubicin/5-fluorouracil/paclitaxel/trastuzumab,cyclophosphamide/methotrexate/trastuzumab,dacomitinib,DHES0815A,docetaxel/lapatinib,docetaxel/pamidronic acid/trastuzumab,docetaxel/pertuzumab/trastuzumab,docetaxel/trastuzumab,docetaxel/trastuzumab/vinorelbine,doxorubicin/lapatinib/paclitaxel/trastuzumab,DS-8201a,eribulin/trastuzumab,erlotinib,erlotinib/osimertinib,ertumaxomab,exemestane/lapatinib,exemestane/lapatinib/trastuzumab,exemestane/pertuzumab/trastuzumab,exemestane/trastuzumab,FS102,fulvestrant/pertuzumab/trastuzumab,fulvestrant/trastuzumab,GBR 1302,gefitinib/osimertinib,gemcitabine/trastuzumab,HER2 inhibitor,I-131-SGMIB,JNJ-26483327,KN026,lapatinib,lapatinib/letrozole,lapatinib/letrozole/trastuzumab,lapatinib/paclitaxel,lapatinib/pazopanib,lapatinib/trastuzumab,letrozole/pertuzumab/trastuzumab,letrozole/trastuzumab,MCLA-128,MEDI4276,MGAH22,MM-111,MM-302,MP 412,MP0274,mubritinib,neratinib,neratinib/paclitaxel,nordihydroguaiaretic acid,osimertinib,paclitaxel/pertuzumab/trastuzumab,paclitaxel/trastuzumab,pelitinib,pertuzumab,pertuzumab/tamoxifen/trastuzumab,pertuzumab/trastuzumab,PF-06804103,pirotinib,poziotinib,PRS-343,pyrotinib,RC48,sapitinib,selatinib,SYD985,sym013,TAK-285,tamoxifen/trastuzumab,TAS0728,tesevatinib,trastuzumab,trastuzumab emtansine,trastuzumab/vinorelbine,tucatinib,varlitinib,XMT-1522,ZW25",2064,13866,24337]
["FGFR1","fibroblast growth factor receptor 1","Fgfr1",1.777,0.83,1.06e-09,9.29e-08," ","Plasma Membrane","kinase","diagnosis,prognosis,unspecified application","5-azacytidine/sorafenib,bortezomib/sorafenib,clofarabine/cytarabine/sorafenib,crizotinib/pazopanib,cytarabine/idarubicin/sorafenib,debio 1347,decitabine/sorafenib,derazantinib,dexamethasone/lenalidomide/sorafenib,docetaxel/nintedanib,everolimus/lenvatinib,everolimus/sorafenib,GSK3052230,imatinib/sorafenib,lenvatinib,lucitanib,nintedanib,orantinib,pazopanib,pemigatinib,PRN1371,regorafenib,SAR103168,sorafenib,sorafenib/sulindac/sunitinib,sulfatinib",2260,14182,79114]
["FGFR2","fibroblast growth factor receptor 2","Fgfr2",-1.373,-0.457,4.04e-05,0.00121," ","Plasma Membrane","kinase","diagnosis,response to therapy,unspecified application","BAY1179470,BAY1187982,bortezomib/dexamethasone/thalidomide,bortezomib/thalidomide,debio 1347,derazantinib,dexamethasone/thalidomide,docetaxel/nintedanib,everolimus/lenvatinib,FPA144,lenvatinib,lucitanib,nintedanib,palifermin,pazopanib,pemigatinib,prednisone/thalidomide,PRN1371,regorafenib,rituximab/thalidomide,thalidomide",2263,14183,25022]
["FGFR3","fibroblast growth factor receptor 3","Fgfr3",5.04,2.333,2.77e-29,1.36e-26," ","Plasma Membrane","kinase","prognosis","B-701,crizotinib/pazopanib,debio 1347,derazantinib,docetaxel/nintedanib,everolimus/lenvatinib,lenvatinib,LY3076226,masitinib,nintedanib,pazopanib,pemigatinib,PRN1371,SAR103168",2261,14184,84489]
["FGFR4","fibroblast growth factor receptor 4","Fgfr4",2.474,1.307,1.79e-16,3.7e-14," ","Plasma Membrane","kinase","unspecified application","BLU-554,everolimus/lenvatinib,FGF401,H3B-6527,INCB062079,lenvatinib,LY2874455,PRN1371,U3-1784",2264,14186,25114]
["FZD1","frizzled class receptor 1","Fzd1",1.346,0.429,0.000435,0.00869," ","Plasma Membrane","G-protein coupled receptor",null,"vantictumab",8321,14362,58868]
["FZD2","frizzled class receptor 2","Fzd2",-1.447,-0.533,0.000213,0.00488," ","Plasma Membrane","G-protein coupled receptor",null,"vantictumab,wnt-5a mimic hexapeptide foxy-5",2535,57265,64512]
["FZD8","frizzled class receptor 8","Fzd8",-1.406,-0.491,0.000873,0.0154," ","Plasma Membrane","G-protein coupled receptor",null,"vantictumab",8325,14370,"364754|100909849"]
["GAB1","GRB2 associated binding protein 1","Gab1",-1.476,-0.562,9.82e-07,4.81e-05," ","Cytoplasm","other",null,null,2549,14388,361388]
["GLI3","GLI family zinc finger 3","Gli3",-1.672,-0.742,7.38e-06,0.000289," ","Nucleus","transcription regulator","efficacy",null,2737,14634,140588]
["GNA14","G protein subunit alpha 14","Gna14",-11.598,-3.536,1.94e-33,1.24e-30," ","Plasma Membrane","enzyme",null,null,9630,14675,309242]
["GNAZ","G protein subunit alpha z","Gnaz",1.468,0.553,3.32e-05,0.00103," ","Plasma Membrane","enzyme",null,null,2781,14687,25740]
["GNG4","G protein subunit gamma 4","Gng4",1.794,0.843,7.64e-07,3.83e-05," ","Plasma Membrane","enzyme",null,null,2786,14706,114118]
["IGF1","insulin like growth factor 1","Igf1",4.083,2.03,5.21e-18,1.21e-15," ","Extracellular Space","growth factor","diagnosis,efficacy,prognosis,safety","BI 836845,MEDI-573",3479,16000,24482]
["KCNJ12","potassium voltage-gated channel subfamily J member 12","Kcnj12",1.612,0.689,0.0024,0.0347," ","Plasma Membrane","ion channel",null,"amiodarone,dofetilide,nicorandil",3768,16515,117052]
["LRRC4C","leucine rich repeat containing 4C","Lrrc4c",1.778,0.83,1.71e-09,1.46e-07," ","Plasma Membrane","other",null,null,57689,241568,311236]
["MMP14","matrix metallopeptidase 14","Mmp14",-1.387,-0.471,0.000822,0.0146," ","Extracellular Space","peptidase","diagnosis,prognosis,unspecified application","BT1718,marimastat,prinomastat,rebimastat",4323,17387,81707]
["NGFR","nerve growth factor receptor","Ngfr",1.955,0.967,0.000387,0.00786," ","Plasma Membrane","transmembrane receptor","disease progression,prognosis","LM11A-31",4804,18053,24596]
["NRP1","neuropilin 1","Nrp1",-1.33,-0.411,0.00115,0.0191," ","Plasma Membrane","transmembrane receptor","diagnosis,efficacy","vesencumab",8829,18186,246331]
["NRP2","neuropilin 2","Nrp2",1.631,0.706,1.33e-05,0.000472," ","Plasma Membrane","kinase",null,null,8828,18187,81527]
["NTF3","neurotrophin 3","Ntf3",-2.507,-1.326,1.17e-06,5.65e-05," ","Extracellular Space","growth factor","diagnosis",null,4908,18205,81737]
["NTN4","netrin 4","Ntn4",-1.792,-0.842,2.59e-10,2.49e-08," ","Extracellular Space","other",null,null,59277,57764,299737]
["NTNG2","netrin G2","Ntng2",-1.645,-0.718,1.25e-07,7.54e-06," ","Plasma Membrane","other",null,null,84628,171171,311836]
["PAK6","p21 (RAC1) activated kinase 6","Pak6",1.451,0.537,8.47e-06,0.000322," ","Cytoplasm","kinase",null,null,56924,214230,296078]
["PLCL2","phospholipase C like 2","Plcl2",1.358,0.441,0.000113,0.00288," ","Cytoplasm","enzyme",null,null,23228,224860,301173]
["PLXND1","plexin D1","Plxnd1",1.916,0.938,1.09e-13,1.76e-11," ","Plasma Membrane","transmembrane receptor",null,null,23129,67784,312652]
["PRKCA","protein kinase C alpha","Prkca",1.586,0.666,0.00128,0.021," ","Cytoplasm","kinase",null,"aprinocarsen,ingenol mebutate,L-threo-safingol",5578,18750,24680]
["PRKCB","protein kinase C beta","Prkcb",3.498,1.807,3.27e-19,8.43e-17," ","Cytoplasm","kinase","diagnosis,efficacy,unspecified application","enzastaurin,ingenol mebutate,ruboxistaurin,sotrastaurin",5579,18751,25023]
["PRKD1","protein kinase D1","Prkd1",-1.407,-0.492,0.000116,0.00294," ","Cytoplasm","kinase",null,null,5587,18760,85421]
["ROBO1","roundabout guidance receptor 1","Robo1",2.796,1.483,3.3e-12,4.41e-10," ","Plasma Membrane","transmembrane receptor",null,null,6091,19876,58946]
["SEMA4D","semaphorin 4D","Sema4d",1.407,0.493,0.00254,0.0361," ","Plasma Membrane","transmembrane receptor",null,"VX15/2503",10507,20354,306790]
["SEMA6A","semaphorin 6A","Sema6a",2.127,1.089,3.62e-08,2.46e-06," ","Plasma Membrane","transmembrane receptor",null,null,57556,20358,361324]
["SEMA6B","semaphorin 6B","Sema6b",1.287,0.364,0.00364,0.0476," ","Plasma Membrane","other","diagnosis",null,10501,20359,84609]
["SLIT2","slit guidance ligand 2","Slit2",2.494,1.318,3.88e-11,4.49e-09," ","Extracellular Space","other","diagnosis",null,9353,20563,360272]
["SLIT3","slit guidance ligand 3","Slit3",2.076,1.054,0.00134,0.0217," ","Extracellular Space","other",null,null,6586,20564,83467]
["WNT3","Wnt family member 3","Wnt3",1.421,0.507,0.0034,0.0453," ","Extracellular Space","other",null,null,7473,22415,24882]
["WNT11","Wnt family member 11","Wnt11",3.135,1.649,6.84e-06,0.000269," ","Extracellular Space","other",null,null,7481,22411,140584]
["WNT7B","Wnt family member 7B","Wnt7b",-2.314,-1.211,2.82e-15,5.06e-13," ","Extracellular Space","other",null,null,7477,22422,315196]